{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:37:59Z","timestamp":1794541079589,"version":"4.9.1"},"reference-count":347,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008736","name":"Fondo de Fomento al Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1200178"],"award-info":[{"award-number":["1200178"]}],"id":[{"id":"10.13039\/501100008736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neurological disorders (NDs) are characterized by progressive neuronal dysfunction leading to synaptic failure, cognitive impairment, and motor injury. Among these diseases, Alzheimer's disease (AD), Parkinson's disease (PD), Huntington\u2019s disease (HD), and amyotrophic lateral sclerosis (ALS) have raised a significant research interest. These disorders present common neuropathological signs, including neuronal dysfunction, protein accumulation, oxidative damage, and mitochondrial abnormalities. In this context, mitochondrial impairment is characterized by a deficiency in ATP production, excessive production of reactive oxygen species, calcium dysregulation, mitochondrial transport failure, and mitochondrial dynamics deficiencies. These defects in mitochondrial health could compromise the synaptic process, leading to early cognitive dysfunction observed in these NDs. Interestingly, skin fibroblasts from AD, PD, HD, and ALS patients have been suggested as a useful strategy to investigate and detect early mitochondrial abnormalities in these NDs. In this context, fibroblasts are considered a viable model for studying neurodegenerative changes due to their metabolic and biochemical relationships with neurons. Also, studies of our group and others have shown impairment of mitochondrial bioenergetics in fibroblasts from patients diagnosed with sporadic and genetic forms of AD, PD, HD, and ALS. Interestingly, these mitochondrial abnormalities have been observed in the brain tissues of patients suffering from the same pathologies. Therefore, fibroblasts represent a novel strategy to study the genesis and progression of mitochondrial dysfunction in AD, PD, HD, and ALS. This review discusses recent evidence that proposes fibroblasts as a potential target to study mitochondrial bioenergetics impairment in neurological disorders and consequently to search for new biomarkers of neurodegeneration.<\/jats:p>","DOI":"10.1186\/s40035-022-00308-y","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T07:21:00Z","timestamp":1656919260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders"],"prefix":"10.1186","volume":"11","author":[{"given":"Margrethe A.","family":"Olesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Villavicencio-Tejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9582-6379","authenticated-orcid":false,"given":"Rodrigo A.","family":"Quintanilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"key":"308_CR1","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1111\/j.1582-4934.2008.00402.x","volume":"12","author":"AM Gorman","year":"2008","unstructured":"Gorman AM. Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling. J Cell Mol Med. 2008;12:2263\u201380.","journal-title":"J Cell Mol Med"},{"key":"308_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","volume":"24","author":"GH Kim","year":"2015","unstructured":"Kim GH, Kim JE, Rhie SJ, Yoon S. The role of oxidative stress in neurodegenerative diseases. Exp Neurobiology. 2015;24:325\u201340.","journal-title":"Exp Neurobiology"},{"key":"308_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15:565\u201381.","journal-title":"Nat Rev Neurol"},{"key":"308_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, et al. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study. Lancet Neurol. 2019;18:459\u201380.","journal-title":"Lancet Neurol"},{"key":"308_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2174\/0929867324666170616110111","volume":"25","author":"C Desler","year":"2019","unstructured":"Desler C, Lillenes MS, T\u00f8njum T, Rasmussen LJ. The Role of mitochondrial dysfunction in the progression of Alzheimer\u2019s disease. Curr Med Chem. 2019;25:5578\u201387.","journal-title":"Curr Med Chem"},{"key":"308_CR6","doi-asserted-by":"publisher","first-page":"16.e7","DOI":"10.1016\/j.neurobiolaging.2015.10.033","volume":"38","author":"A Pyle","year":"2016","unstructured":"Pyle A, Anugrha H, Kurzawa-Akanbi M, Yarnall A, Burn D, Hudson G. Reduced mitochondrial DNA copy number is a biomarker of Parkinson\u2019s disease. Neurobiol Aging. 2016;38:16.e7-216.e10.","journal-title":"Neurobiol Aging"},{"key":"308_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.dnarep.2008.09.004","volume":"8","author":"K Acevedo-Torres","year":"2009","unstructured":"Acevedo-Torres K, Berr\u00edos L, Rosario N, Dufault V, Skatchkov S, Eaton MJ, et al. Mitochondrial DNA damage is a hallmark of chemically induced and the R6\/2 transgenic model of Huntington\u2019s disease. DNA Repair. 2009;8:126\u201336.","journal-title":"DNA Repair"},{"key":"308_CR8","first-page":"5","volume":"1802","author":"P Shi","year":"2010","unstructured":"Shi P, Gal J, Kwinter DM, Liu X, Zhu H. Mitochondrial dysfunction in amyotrophic lateral sclerosis. Biochim Biophys Acta. 2010;1802:5\u201351.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"308_CR9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/jpet.112.192138","volume":"342","author":"A Johri","year":"2012","unstructured":"Johri A, Bea MF. Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther. 2012;342(3):619\u201330.","journal-title":"J Pharmacol Exp Ther"},{"key":"308_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.yexcr.2015.01.004","volume":"334","author":"MY Lin","year":"2015","unstructured":"Lin MY, Sheng ZH. Regulation of mitochondrial transport in neurons. Exp Cell Res. 2015;334:5\u201344.","journal-title":"Exp Cell Res"},{"key":"308_CR11","doi-asserted-by":"publisher","first-page":"077","DOI":"10.1038\/s42255-020-00289-0","volume":"2","author":"S Li","year":"2020","unstructured":"Li S, Xiong GJ, Huang N, Sheng ZH. The cross-talk of energy sensing and mitochondrial anchoring sustains synaptic efficacy by maintaining presynaptic metabolism. Nat Metabolism. 2020;2:1077\u201395.","journal-title":"Nat Metabolism"},{"issue":"3","key":"308_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/jnc.13410","volume":"136","author":"A R\u00f6nnb\u00e4ck","year":"2016","unstructured":"R\u00f6nnb\u00e4ck A, Pavlov PF, Mansory M, Gonze P, Marli\u00e8re N, Winblad B, et al. Mitochondrial dysfunction in a transgenic mouse model expressing human amyloid precursor protein (APP) with the Arctic mutation. J Neurochem. 2016;136(3):497\u2013502.","journal-title":"J Neurochem"},{"key":"308_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/hmg\/ddm083","volume":"16","author":"CC Stichel","year":"2007","unstructured":"Stichel CC, Zhu XR, Bader V, Linnartz B, Schmidt S, L\u00fcbbert H. Mono- and double-mutant mouse models of Parkinson\u2019s disease display severe mitochondrial damage. Hum Mol Genet. 2007;16:2377\u201393.","journal-title":"Hum Mol Genet"},{"key":"308_CR14","first-page":"49","volume":"14","author":"U Shefa","year":"2019","unstructured":"Shefa U, Jeong N, Song I, Chung HJ, Kim D, Jung J, et al. Mitophagy links oxidative stress conditions and neurodegenerative diseases. Neural Regen Res. 2019;14:49.","journal-title":"Neural Regen Res"},{"key":"308_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fnins.2017.00473","volume":"11","author":"RS Rogers","year":"2017","unstructured":"Rogers RS, Tungtur S, Tanaka T, Nadeau LL, Badawi Y, Wang H, et al. Impaired mitophagy plays a role in denervation of neuromuscular junctions in ALS mice. Front Neurosci. 2017;11:73.","journal-title":"Front Neurosci"},{"key":"308_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1155\/2015\/509654","volume":"2015","author":"FA Cabezas-Opazo","year":"2015","unstructured":"Cabezas-Opazo FA, Vergara-Pulgar K, P\u00e9rez MJ, Jara C, Osorio-Fuentealba C, Quintanilla RA. Mitochondrial dysfunction contributes to the pathogenesis of Alzheimer\u2019s disease. Oxid Med Cell Longev. 2015;2015:12.","journal-title":"Oxid Med Cell Longev"},{"key":"308_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K","volume":"47","author":"SJ Tabrizi","year":"2000","unstructured":"Tabrizi SJ, Workman J, Hart PE, Mangiarini L, Mahal A, Bates G, et al. Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 transgenic mouse. Ann Neurol. 2000;47:1\u201386.","journal-title":"Ann Neurol"},{"key":"308_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41593-018-0236-8","volume":"21","author":"TM Dawson","year":"2018","unstructured":"Dawson TM, Golde TE, Lagier-Tourenne C. Animal models of neurodegenerative diseases. Nat Neurosci. 2018;21:1370\u20139.","journal-title":"Nat Neurosci"},{"key":"308_CR19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbrc.2016.11.018","volume":"481","author":"V Altanbyek","year":"2016","unstructured":"Altanbyek V, Cha SJ, Kang GU, Im DS, Lee S, Kim HJ, et al. Imbalance of mitochondrial dynamics in Drosophila models of amyotrophic lateral sclerosis. Biochem Bioph Res. 2016;481:259\u201364.","journal-title":"Biochem Bioph Res"},{"key":"308_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuint.2013.05.005","volume":"63","author":"R Selvatici","year":"2013","unstructured":"Selvatici R, Marani L, Marino S, Siniscalchi A. In vitro mitochondrial failure and oxidative stress mimic biochemical features of Alzheimer disease. Neurochem Int. 2013;63:112\u201320.","journal-title":"Neurochem Int"},{"key":"308_CR21","doi-asserted-by":"publisher","first-page":"01","DOI":"10.1038\/4789","volume":"5","author":"Q Guo","year":"1999","unstructured":"Guo Q, Fu W, Sopher BL, Miller MW, Ware CB, Martin GM, et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med. 1999;5:101\u20136.","journal-title":"Nat Med"},{"key":"308_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1471-4159.2004.02728.x","volume":"91","author":"M Yamada","year":"2004","unstructured":"Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H. Overexpression of \u03b1-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of \u03b1-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson\u2019s disease. J Neurochem. 2004;91:451\u201361.","journal-title":"J Neurochem"},{"key":"308_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.nbd.2011.09.001","volume":"45","author":"L Devi","year":"2012","unstructured":"Devi L, Ohno M. Mitochondrial dysfunction and accumulation of the \u03b2-secretase-cleaved C-terminal fragment of APP in Alzheimer\u2019s disease transgenic mice. Neurobiol Dis. 2012;45:417\u201324.","journal-title":"Neurobiol Dis"},{"key":"308_CR24","doi-asserted-by":"crossref","unstructured":"Park JH, Burgess JD, Faroqi AH, DeMeo NN, Fiesel FC, Springer W, et al. Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway. Mol Neurodegener. 2020;15","DOI":"10.1186\/s13024-019-0349-x"},{"key":"308_CR25","first-page":"385","volume":"1842","author":"G Ambrosi","year":"2014","unstructured":"Ambrosi G, Ghezzi C, Sepe S, Milanese C, Payan-Gomez C, Bombardieri CR, et al. Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson\u2019s disease. Biochim Biophys Acta. 2014;1842:1385\u201394.","journal-title":"Biochim Biophys Acta"},{"key":"308_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ana.24244","volume":"76","author":"K Kirk","year":"2014","unstructured":"Kirk K, Gennings C, Hupf JC, Tadesse S, D\u2019Aurelio M, Kawamata H, et al. Bioenergetic markers in skin fibroblasts of sporadic ALS and PLS patients. Ann Neurol. 2014;76:620\u201324.","journal-title":"Ann Neurol"},{"key":"308_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12035-015-9435-4","volume":"53","author":"GA Smith","year":"2016","unstructured":"Smith GA, Jansson J, Rocha EM, Osborn T, Hallett PJ, Isacson O. Fibroblast biomarkers of sporadic Parkinson\u2019s disease and LRRK2 kinase inhibition. Mol Neurobiol. 2016;53:5161\u201377.","journal-title":"Mol Neurobiol"},{"key":"308_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41598-020-58505-6","volume":"10","author":"PMA Antony","year":"2020","unstructured":"Antony PMA, Kondratyeva O, Mommaerts K, Ostaszewski M, Sokolowska K, Baumuratov AS, et al. Fibroblast mitochondria in idiopathic Parkinson\u2019s disease display morphological changes and enhanced resistance to depolarization. Sci Rep. 2020;10:569.","journal-title":"Sci Rep"},{"key":"308_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnins.2017.00553","volume":"11","author":"MJ P\u00e9rez","year":"2017","unstructured":"P\u00e9rez MJ, Ponce DP, Osorio-Fuentealba C, Behrens MI, Quintanilla RA. Mitochondrial bioenergetics is altered in fibroblasts from patients with sporadic Alzheimer\u2019s disease. Front Neurosci. 2017;11:53.","journal-title":"Front Neurosci"},{"key":"308_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12640-015-9532-1","volume":"28","author":"S Yang","year":"2015","unstructured":"Yang S, Zhang KY, Kariawasam R, Bax M, Fifita JA, Ooi L, et al. Evaluation of skin fibroblasts from amyotrophic lateral sclerosis patients for the rapid study of pathological features. Neurotox Res. 2015;28:138\u201346.","journal-title":"Neurotox Res"},{"key":"308_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2014.10.016","volume":"84","author":"MB Victor","year":"2014","unstructured":"Victor MB, Richner M, Hermanstyne TO, Ransdell JL, Sobieski C, Deng PY, et al. Generation of human striatal neurons by microrna-dependent direct conversion of fibroblasts. Neuron. 2014;84:311\u201323.","journal-title":"Neuron"},{"key":"308_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/cr.2011.181","volume":"22","author":"X Liu","year":"2012","unstructured":"Liu X, Li F, Stubblefield EA, Blanchard B, Richards TL, Larson GA, et al. Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell Res. 2012;22:321\u201332.","journal-title":"Cell Res"},{"key":"308_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nature10284","volume":"476","author":"M Caiazzo","year":"2011","unstructured":"Caiazzo M, Dell\u2019Anno MT, Dvoretskova E, Lazarevic D, Taverna S, Leo D, et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature. 2011;476:224\u20137.","journal-title":"Nature"},{"key":"308_CR34","doi-asserted-by":"publisher","first-page":"035","DOI":"10.1038\/nature08797","volume":"463","author":"T Vierbuchen","year":"2010","unstructured":"Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, S\u00fcdhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature. 2010;463:1035\u201341.","journal-title":"Nature"},{"key":"308_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.stemcr.2019.09.007","volume":"13","author":"Y Yang","year":"2019","unstructured":"Yang Y, Chen R, Wu X, Zhao Y, Fan Y, Xiao Z, et al. Rapid and efficient conversion of human fibroblasts into functional neurons by small molecules. Stem Cell Rep. 2019;13:862\u201376.","journal-title":"Stem Cell Rep"},{"key":"308_CR36","first-page":"65615","volume":"1866","author":"CM Deus","year":"2020","unstructured":"Deus CM, Pereira SP, Cunha-Oliveira T, Pereira FB, Raimundo N, Oliveira PJ. Mitochondrial remodeling in human skin fibroblasts from sporadic male Parkinson\u2019s disease patients uncovers metabolic and mitochondrial bioenergetic defects. Biochim Biophys Acta. 2020;1866:65615.","journal-title":"Biochim Biophys Acta"},{"key":"308_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/toxsci\/kfy068","volume":"164","author":"SP Pereira","year":"2018","unstructured":"Pereira SP, Deus CM, Serafim TL, Cunha-Oliveira T, Oliveira PJ. Metabolic and phenotypic characterization of human skin fibroblasts after forcing oxidative capacity. Toxicol Sci. 2018;164:191\u2013204.","journal-title":"Toxicol Sci"},{"key":"308_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3233\/JAD-2010-091522","volume":"21","author":"A Magini","year":"2010","unstructured":"Magini A, Urbanelli L, Ciccarone V, Tancini B, Polidoro M, Timperio AM, et al. Fibroblasts from PS1 mutated pre-symptomatic subjects and Alzheimer\u2019s disease patients share a unique protein levels profile. J Alzheimers Dis. 2010;21:431\u201344.","journal-title":"J Alzheimers Dis"},{"key":"308_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.redox.2018.09.001","volume":"19","author":"MJ P\u00e9rez","year":"2018","unstructured":"P\u00e9rez MJ, Ponce DP, Aranguiz A, Behrens MI, Quintanilla RA. Mitochondrial permeability transition pore contributes to mitochondrial dysfunction in fibroblasts of patients with sporadic Alzheimer\u2019s disease. Redox Biol. 2018;19:290\u2013300.","journal-title":"Redox Biol"},{"key":"308_CR40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11064-006-9110-2","volume":"31","author":"P del Hoyo","year":"2006","unstructured":"del Hoyo P, Garc\u00eda-Redondo A, de Bustos F, Molina JA, Sayed Y, Alonso-Navarro H, et al. Oxidative stress in skin fibroblasts cultures of patients with Huntington\u2019s disease. Neurochem Res. 2006;31:1103\u20139.","journal-title":"Neurochem Res"},{"key":"308_CR41","doi-asserted-by":"publisher","first-page":"09591","DOI":"10.1016\/j.cellsig.2020.109591","volume":"70","author":"N Romano","year":"2020","unstructured":"Romano N, Catalani A, Lattante S, Belardo A, Proietti S, Bertini L, et al. ALS skin fibroblasts reveal oxidative stress and ERK1\/2-mediated cytoplasmic localization of TDP-43. Cell Signal. 2020;70:09591.","journal-title":"Cell Signal"},{"key":"308_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12915-015-0201-x","volume":"13","author":"W K\u00fchlbrandt","year":"2015","unstructured":"K\u00fchlbrandt W. Structure and function of mitochondrial membrane protein complexes. BMC Biol. 2015;13:9.","journal-title":"BMC Biol"},{"key":"308_CR43","volume":"5","author":"AM Bliek","year":"2013","unstructured":"Bliek AM, van der Shen Q, Kawajiri S. Mechanisms of mitochondrial fission and fusion. Cold Spring Harb Perspect Biol. 2013;5: a011072.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"308_CR44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/nrm2275","volume":"8","author":"SA Detmer","year":"2007","unstructured":"Detmer SA, Chan DC. Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Bio. 2007;8:870\u20139.","journal-title":"Nat Rev Mol Cell Bio"},{"key":"308_CR45","doi-asserted-by":"publisher","first-page":"388","DOI":"10.15252\/embj.201488327","volume":"33","author":"A Martorell-Riera","year":"2014","unstructured":"Martorell-Riera A, Segarra-Mondejar M, Mu\u00f1oz JP, Ginet V, Olloquequi J, P\u00e9rez-Clausell J, et al. Mfn2 downregulation in excitotoxicity causes mitochondrial dysfunction and delayed neuronal death. EMBO J. 2014;33:2388\u20132407.","journal-title":"EMBO J"},{"key":"308_CR46","first-page":"67","volume":"87","author":"JS Sousa","year":"2018","unstructured":"Sousa JS, D\u2019Imprima E, Vonck J. Membrane protein complexes: structure and function. Subcell Biochem. 2018;87:167\u2013227.","journal-title":"Subcell Biochem"},{"key":"308_CR47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1146\/annurev.bi.63.070194.003331","volume":"63","author":"BL Trumpower","year":"1994","unstructured":"Trumpower BL, Gennis RB. Energy transduction by cytochrome complexes in mitochondrial and bacterial respiration: the enzymology of coupling electron transfer reactions to transmembrane proton translocation. Annu Rev Biochem. 1994;63:675\u2013716.","journal-title":"Annu Rev Biochem"},{"key":"308_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1042\/BJ20081386","volume":"417","author":"MP Murphy","year":"2009","unstructured":"Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417:13.","journal-title":"Biochem J"},{"key":"308_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1017\/S1092852900024901","volume":"14","author":"PH Reddy","year":"2009","unstructured":"Reddy PH. Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in neurodegenerative diseases. CNS Spectr. 2009;14:18.","journal-title":"CNS Spectr"},{"key":"308_CR50","first-page":"07","volume":"1320","author":"C H\u00e4gerh\u00e4ll","year":"1997","unstructured":"H\u00e4gerh\u00e4ll C. Succinate: quinone oxidoreductases. Biochim Biophys Acta BBA Bioenerg. 1997;1320:107\u201341.","journal-title":"Biochim Biophys Acta BBA Bioenerg"},{"key":"308_CR51","first-page":"287","volume":"57","author":"P Maher","year":"2000","unstructured":"Maher P, Schubert D. Signaling by reactive oxygen species in the nervous system. Cell Mol Life Sci Cmls. 2000;57:1287\u2013305.","journal-title":"Cell Mol Life Sci Cmls"},{"key":"308_CR52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.molcel.2012.09.025","volume":"48","author":"LA Sena","year":"2012","unstructured":"Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell. 2012;48:158\u201367.","journal-title":"Mol Cell"},{"key":"308_CR53","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/cells9092135","volume":"9","author":"N Esteras","year":"2020","unstructured":"Esteras N, Abramov AY. Mitochondrial calcium deregulation in the mechanism of beta-amyloid and tau pathology. Cells. 2020;9:135.","journal-title":"Cells"},{"key":"308_CR54","doi-asserted-by":"crossref","unstructured":"Marchi ED, Bonora M, Giorgi C, Pinton P. The mitochondrial permeability transition pore is a dispensable element for mitochondrial calcium efflux. Cell Calcium. 2014;56:13.","DOI":"10.1016\/j.ceca.2014.03.004"},{"key":"308_CR55","first-page":"13","volume":"19","author":"C Giorgi","year":"2018","unstructured":"Giorgi C, Marchi S, Pinton P. The machineries, regulation and cellular functions of mitochondrial calcium. Nat Rev Mol Cell Bio. 2018;19:713\u201330.","journal-title":"Nat Rev Mol Cell Bio"},{"issue":"9","key":"308_CR56","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.bbamcr.2015.04.008","volume":"1853","author":"DD Stefani","year":"2015","unstructured":"Stefani DD, Patron M, Rizzuto R. Structure and function of the mitochondrial calcium uniporter complex. Biochim Biophys Acta. 2015;1853(9):2006\u201311.","journal-title":"Biochim Biophys Acta"},{"key":"308_CR57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10863-016-9652-1","volume":"49","author":"N Mnatsakanyan","year":"2017","unstructured":"Mnatsakanyan N, Beutner G, Porter GA, Alavian KN, Jonas EA. Physiological roles of the mitochondrial permeability transition pore. J Bioenerg Biomembr. 2017;49:3\u201325.","journal-title":"J Bioenerg Biomembr"},{"key":"308_CR58","doi-asserted-by":"publisher","first-page":"080","DOI":"10.1074\/jbc.M115.686956","volume":"291","author":"JRK Marland","year":"2016","unstructured":"Marland JRK, Hasel P, Bonnycastle K, Cousin MA. Mitochondrial calcium uptake modulates synaptic vesicle endocytosis in central nerve terminals. J Biol Chem. 2016;291:2080\u201386.","journal-title":"J Biol Chem"},{"key":"308_CR59","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41467-020-16074-2","volume":"11","author":"M Calvo-Rodriguez","year":"2020","unstructured":"Calvo-Rodriguez M, Hou SS, Snyder AC, Kharitonova EK, Russ AN, Das S, et al. Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer\u2019s disease. Nat Commun. 2020;11:146.","journal-title":"Nat Commun"},{"key":"308_CR60","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.brainresbull.2009.07.010","volume":"80","author":"RA Quintanilla","year":"2009","unstructured":"Quintanilla RA, Johnson GVW. Role of mitochondrial dysfunction in the pathogenesis of Huntington\u2019s disease. Brain Res Bull. 2009;80:242\u201347.","journal-title":"Brain Res Bull"},{"key":"308_CR61","doi-asserted-by":"crossref","first-page":"030","DOI":"10.1046\/j.1471-4159.1999.0721030.x","volume":"72","author":"JG Begley","year":"1999","unstructured":"Begley JG, Duan W, Chan S, Duff K, Mattson MP. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of Presenilin-1 mutant mice. J Neurochem. 1999;72:1030\u20139.","journal-title":"J Neurochem"},{"key":"308_CR62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.freeradbiomed.2015.04.036","volume":"88","author":"AT Dinkova-Kostova","year":"2015","unstructured":"Dinkova-Kostova AT, Abramov AY. The emerging role of Nrf2 in mitochondrial function. Free Radical Bio Med. 2015;88:179\u201388.","journal-title":"Free Radical Bio Med"},{"key":"308_CR63","doi-asserted-by":"publisher","first-page":"069","DOI":"10.3390\/antiox10071069","volume":"10","author":"F Villavicencio-Tejo","year":"2021","unstructured":"Villavicencio-Tejo F, Quintanilla RA. Contribution of the Nrf2 pathway on oxidative damage and mitochondrial failure in Parkinson and Alzheimer\u2019s disease. Antioxidants. 2021;10:069.","journal-title":"Antioxidants"},{"key":"308_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/antiox11030515","volume":"11","author":"F Villavicencio-Tejo","year":"2022","unstructured":"Villavicencio-Tejo F, Olesen MA, Ar\u00e1nguiz A, Quintanilla RA. Activation of the Nrf2 pathway prevents mitochondrial dysfunction induced by caspase-3 cleaved tau: implications for Alzheimer\u2019s disease. Antioxidants. 2022;11:15.","journal-title":"Antioxidants"},{"key":"308_CR65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.redox.2018.07.010","volume":"18","author":"C Jara","year":"2018","unstructured":"Jara C, Ar\u00e1nguiz A, Cerpa W, Tapia-Rojas C, Quintanilla RA. Genetic ablation of tau improves mitochondrial function and cognitive abilities in the hippocampus. Redox Biol. 2018;18:279\u201394.","journal-title":"Redox Biol"},{"key":"308_CR66","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.redox.2017.10.010","volume":"14","author":"A Cuadrado","year":"2018","unstructured":"Cuadrado A, K\u00fcgler S, Lastres-Becker I. Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy. Redox Biol. 2018;14:522\u201334.","journal-title":"Redox Biol"},{"key":"308_CR67","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuro.2012.01.015","volume":"33","author":"TP Williamson","year":"2012","unstructured":"Williamson TP, Johnson DA, Johnson JA. Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity. Neurotoxicology. 2012;33:272\u201379.","journal-title":"Neurotoxicology"},{"key":"308_CR68","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3233\/JAD-161032","volume":"56","author":"Q Wang","year":"2017","unstructured":"Wang Q, Li WX, Dai SX, Guo YC, Han FF, Zheng JJ, et al. Meta-analysis of Parkinson\u2019s disease and Alzheimer\u2019s disease revealed commonly impaired pathways and dysregulation of NRF2-dependent genes. J Alzheimers Dis. 2017;56:1525\u201339.","journal-title":"J Alzheimers Dis"},{"key":"308_CR69","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrneurol.2011.2","volume":"7","author":"C Reitz","year":"2011","unstructured":"Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7:137\u201352.","journal-title":"Nat Rev Neurol"},{"key":"308_CR70","doi-asserted-by":"publisher","first-page":"45","DOI":"10.31887\/DCNS.2013.15.4\/hjahn","volume":"15","author":"H Jahn","year":"2013","unstructured":"Jahn H. Memory loss in Alzheimer\u2019s disease. Dialogues Clin Neurosc. 2013;15:445\u201354.","journal-title":"Dialogues Clin Neurosc"},{"key":"308_CR71","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3233\/JAD-2009-0960","volume":"16","author":"HC Huang","year":"2009","unstructured":"Huang HC, Jiang ZF. Accumulated amyloid-\u03b2 peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer\u2019s disease. J Alzheimers Dis. 2009;16:25\u20137.","journal-title":"J Alzheimers Dis"},{"key":"308_CR72","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jalz.2016.02.002","volume":"12","author":"B Dubois","year":"2016","unstructured":"Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, et al. Preclinical Alzheimer\u2019s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12:292\u2013323.","journal-title":"Alzheimers Dement"},{"key":"308_CR73","volume-title":"Update on Dementia","author":"MJ P\u00e9rez","year":"2016","unstructured":"P\u00e9rez MJ, Jara C, Mu\u00f1oz-Urrutia E, Quintanilla RA. New targets for diagnosis and treatment against Alzheimer\u2019s disease: the mitochondrial approach. In: Moretti DV, editor. Update on Dementia. London: IntechOpen; 2016."},{"key":"308_CR74","doi-asserted-by":"publisher","first-page":"076","DOI":"10.2174\/1570159X18666200525020259","volume":"18","author":"RA Quntanilla","year":"2020","unstructured":"Quntanilla RA, Tapia-Monsalves C. The role of mitochondrial impairment in alzheimer\u00b4s disease neurodegeneration: the tau connection. Curr Neuropharmacol. 2020;18:1076\u201391.","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"308_CR75","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.bbadis.2011.10.011","volume":"1822","author":"PH Reddy","year":"2012","unstructured":"Reddy PH, Tripathi R, Troung Q, Tirumala K, Reddy TP, Anekonda V, et al. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer\u2019s disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim Biophys Acta. 2012;1822(5):639\u201349.","journal-title":"Biochim Biophys Acta"},{"key":"308_CR76","doi-asserted-by":"publisher","first-page":"090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","volume":"29","author":"X Wang","year":"2009","unstructured":"Wang X, Su B, Lee H, Li X, Perry G, Smith MA, et al. Impaired balance of mitochondrial fission and fusion in Alzheimer\u2019s disease. J Neurosci. 2009;29:9090\u2013103.","journal-title":"J Neurosci"},{"key":"308_CR77","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/hmg\/ddx299","volume":"26","author":"W Wang","year":"2017","unstructured":"Wang W, Yin J, Ma X, Zhao F, Siedlak SL, Wang Z, et al. Inhibition of mitochondrial fragmentation protects against Alzheimer\u2019s disease in rodent model. Hum Mol Genet. 2017;26:4118\u201331.","journal-title":"Hum Mol Genet"},{"key":"308_CR78","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/hmg\/ddr139","volume":"20","author":"M Manczak","year":"2011","unstructured":"Manczak M, Calkins MJ, Reddy PH. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer\u2019s disease: implications for neuronal damage. Hum Mol Genet. 2011;20:2495\u2013509.","journal-title":"Hum Mol Genet"},{"key":"308_CR79","first-page":"03","volume":"273","author":"SW Chang","year":"2000","unstructured":"Chang SW, Zhang D, Chung HD, Zassenhaus HP. The frequency of point mutations in mitochondrial DNA is elevated in the Alzheimer\u2019s Brain. Biochem Bioph Res. 2000;273:203\u20138.","journal-title":"Biochem Bioph Res"},{"key":"308_CR80","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0197-4580(00)00112-3","volume":"21","author":"I Maurer","year":"2000","unstructured":"Maurer I, Zierz S, M\u00f6ller H. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging. 2000;21:455\u201362.","journal-title":"Neurobiol Aging"},{"key":"308_CR81","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1471-4159.1994.63062179.x","volume":"63","author":"EM Mutisya","year":"1994","unstructured":"Mutisya EM, Bowling AC, Beal MF. Cortical cytochrome oxidase activity is reduced in Alzheimer\u2019s disease.pdf. J Neurochem. 1994;63:179\u201384.","journal-title":"J Neurochem"},{"key":"308_CR82","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.brainres.2006.09.106","volume":"1127","author":"WM Brooks","year":"2007","unstructured":"Brooks WM, Lynch PJ, Ingle CC, Hatton A, Emson PC, Faull RLM, et al. Gene expression profiles of metabolic enzyme transcripts in Alzheimer\u2019s disease. Brain Res. 2007;1127:127\u201335.","journal-title":"Brain Res"},{"key":"308_CR83","first-page":"35","volume":"79","author":"A Stojakovic","year":"2021","unstructured":"Stojakovic A, Chang SY, Nesbitt J, Pichurin NP, Ostroot MA, Aikawa T, et al. Partial inhibition of mitochondrial complex I reduces tau pathology and improves energy homeostasis and synaptic function in 3xTg-AD mice. J Alzheimer\u2019s Dis. 2021;79:335\u201353.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"308_CR84","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1074\/jbc.M808908200","volume":"284","author":"RA Quintanilla","year":"2009","unstructured":"Quintanilla RA, Matthews-Roberson TA, Dolan PJ, Johnson GVW. Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer\u2019disease. J Biol Chem. 2009;284:18754\u201366.","journal-title":"J Biol Chem"},{"key":"308_CR85","doi-asserted-by":"publisher","first-page":"004","DOI":"10.1007\/s12035-017-0385-x","volume":"55","author":"MJ P\u00e9rez","year":"2018","unstructured":"P\u00e9rez MJ, Vergara-Pulgar K, Jara C, Cabezas-Opazo F, Quintanilla RA. Caspase-cleaved tau impairs mitochondrial dynamics in Alzheimer\u2019s disease. Mol Neurobiol. 2018;55:1004\u201318.","journal-title":"Mol Neurobiol"},{"key":"308_CR86","doi-asserted-by":"publisher","first-page":"01","DOI":"10.3233\/JAD-2008-14407","volume":"14","author":"F Garc\u00eda-Sierra","year":"2008","unstructured":"Garc\u00eda-Sierra F, Mondrag\u00f3n-Rodr\u00edguez S, Basurto-Islas G. Truncation of Tau protein and its pathological significance in Alzheimer\u2019s disease. J Alzheimers Dis. 2008;14:01\u20139.","journal-title":"J Alzheimers Dis"},{"key":"308_CR87","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fncel.2020.00175","volume":"14","author":"RA Quintanilla","year":"2020","unstructured":"Quintanilla RA, Tapia-Monsalves C, Vergara EH, P\u00e9rez MJ, Aranguiz A. Truncated tau induces mitochondrial transport failure through the impairment of TRAK2 protein and bioenergetics decline in neuronal cells. Front Cell Neurosci. 2020;14:75.","journal-title":"Front Cell Neurosci"},{"key":"308_CR88","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fnins.2018.00163","volume":"12","author":"Y Cheng","year":"2018","unstructured":"Cheng Y, Bai F. The association of tau with mitochondrial dysfunction in Alzheimer\u2019s disease. Front Neurosci. 2018;12:63.","journal-title":"Front Neurosci"},{"key":"308_CR89","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1074\/jbc.M500356200","volume":"280","author":"DC David","year":"2005","unstructured":"David DC, Hauptmann S, Scherping I, Schuessel K, Keil U, Rizzu P, et al. Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J Biol Chem. 2005;280:23802\u2013814.","journal-title":"J Biol Chem"},{"key":"308_CR90","first-page":"55","volume":"145","author":"GG Kovacs","year":"2017","unstructured":"Kovacs GG. Chapter 25 Tauopathies. Handb Clin Neurol. 2017;145:355\u201368.","journal-title":"Handb Clin Neurol"},{"key":"308_CR91","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/hmg\/ddw312","volume":"25","author":"R Kandimalla","year":"2016","unstructured":"Kandimalla R, Manczak M, Fry D, Suneetha Y, Sesaki H, Reddy PH. Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer\u2019s disease. Hum Mol Genet. 2016;25:4881\u201397.","journal-title":"Hum Mol Genet"},{"key":"308_CR92","first-page":"20","volume":"1842","author":"X Gan","year":"2014","unstructured":"Gan X, Huang S, Wu L, Wang Y, Hu G, Li G, et al. Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer\u2019s disease cybrid cell. Biochim Biophys Acta. 2014;1842:220\u201331.","journal-title":"Biochim Biophys Acta"},{"key":"308_CR93","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41467-019-11813-6","volume":"10","author":"P Jadiya","year":"2019","unstructured":"Jadiya P, Kolmetzky DW, Tomar D, Meco AD, Lombardi AA, Lambert JP, et al. Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer\u2019s disease. Nat Commun. 2019;10:885.","journal-title":"Nat Commun"},{"key":"308_CR94","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/ijms21239153","volume":"21","author":"KC Ryan","year":"2020","unstructured":"Ryan KC, Ashkavand Z, Norman KR. The role of mitochondrial calcium homeostasis in Alzheimer\u2019s and related diseases. Int J Mol Sci. 2020;21:153.","journal-title":"Int J Mol Sci"},{"key":"308_CR95","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0896-6273(88)90162-6","volume":"1","author":"DW Choi","year":"1988","unstructured":"Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1:623\u201334.","journal-title":"Neuron"},{"key":"308_CR96","doi-asserted-by":"publisher","DOI":"10.1042\/AN20110031","volume":"4","author":"KA Hosie","year":"2012","unstructured":"Hosie KA, King AE, Blizzard CA, Vickers JC, Dickson TC. Chronic excitotoxin-induced axon degeneration in a compartmented neuronal culture model. ASN Neuro. 2012;4: e00076.","journal-title":"ASN Neuro"},{"key":"308_CR97","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1523\/JNEUROSCI.10-01-00283.1990","volume":"10","author":"RL Michaels","year":"1990","unstructured":"Michaels RL, Rochman SL. Glutamate neurotoxicity in vitro- antagonist pharmacology and intracellular calcium concentrations. J Neurosci. 1990;10:283\u201392.","journal-title":"J Neurosci"},{"key":"308_CR98","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1523\/JNEUROSCI.0531-04.2004","volume":"24","author":"NB Pivovarova","year":"2004","unstructured":"Pivovarova NB, Nguyen HV, Winters CA, Brantner CA, Smith CL, Andrews SB. Excitotoxic calcium overload in a subpopulation of mitochondria triggers delayed death in hippocampal neurons. J Neurosci. 2004;24:5611\u201322.","journal-title":"J Neurosci"},{"key":"308_CR99","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1523\/JNEUROSCI.16-19-06125.1996","volume":"16","author":"AF Schinder","year":"1996","unstructured":"Schinder AF, Olson EC, Spitzer NC, Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci. 1996;16:6125\u201333.","journal-title":"J Neurosci"},{"key":"308_CR100","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.nbd.2015.10.007","volume":"85","author":"T Rodr\u00edguez-Mart\u00edn","year":"2016","unstructured":"Rodr\u00edguez-Mart\u00edn T, Pooler AM, Lau DHW, M\u00f3rotz GM, Vos KJD, Gilley J, et al. Reduced number of axonal mitochondria and tau hypophosphorylation in mouse P301L tau knockin neurons. Neurobiol Dis. 2016;85:10.","journal-title":"Neurobiol Dis"},{"key":"308_CR101","first-page":"1","volume":"27","author":"R Kandimalla","year":"2017","unstructured":"Kandimalla R, Manczak M, Yin X, Wang R, Reddy PH. Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer\u2019s disease. Hum Mol Genet. 2017;27:1\u201340.","journal-title":"Hum Mol Genet"},{"key":"308_CR102","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3233\/JAD-130728","volume":"37","author":"N Krako","year":"2013","unstructured":"Krako N, Magnifico MC, Arese M, Meli G, Forte E, Lecci A, et al. Characterization of mitochondrial dysfunction in the 7PA2 cell model of Alzheimer\u2019s disease. J Alzheimers Dis. 2013;37:747\u201358.","journal-title":"J Alzheimers Dis"},{"key":"308_CR103","doi-asserted-by":"publisher","first-page":"8670","DOI":"10.1073\/pnas.1006586107","volume":"107","author":"H Du","year":"2010","unstructured":"Du H, Guo L, Yan S, Sosunov AA, McKhann GM, Yan SS. Early deficits in synaptic mitochondria in an Alzheimer\u2019s disease mouse model. Proc Natl Acad Sci U S A. 2010;107:18670\u201375.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"308_CR104","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.neurobiolaging.2011.02.007","volume":"33","author":"RA Quintanilla","year":"2012","unstructured":"Quintanilla RA, Dolan PJ, Jin YN, Johnson GVW. Truncated tau and A\u03b2 cooperatively impair mitochondria in primary neurons. Neurobiol Aging. 2012;33:61925\u201335.","journal-title":"Neurobiol Aging"},{"key":"308_CR105","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/ncomms11483","volume":"7","author":"SJ Beck","year":"2016","unstructured":"Beck SJ, Guo L, Phensy A, Tian J, Wang L, Tandon N, et al. Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer\u2019s disease. Nat Commun. 2016;7:1483.","journal-title":"Nat Commun"},{"key":"308_CR106","doi-asserted-by":"publisher","first-page":"4670","DOI":"10.1073\/pnas.0903563106","volume":"106","author":"J Yao","year":"2009","unstructured":"Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. Mitochondrial bioenergetic deficit precedes Alzheimer\u2019s pathology in female mouse model of Alzheimer\u2019s diseasepdf. Proc Natl Acad Sci U S A. 2009;106:4670\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"308_CR107","doi-asserted-by":"publisher","first-page":"011","DOI":"10.1523\/JNEUROSCI.1189-06.2006","volume":"26","author":"A Deshpande","year":"2006","unstructured":"Deshpande A, Mina E, Glabe C, Busciglio J. Different conformations of amyloid \u03b2 induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci. 2006;26:6011\u20138.","journal-title":"J Neurosci"},{"key":"308_CR108","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.1523\/JNEUROSCI.1836-13.2013","volume":"33","author":"H Xie","year":"2013","unstructured":"Xie H, Guan J, Borrelli LA, Xu J, Serrano-Pozo A, Bacskai BJ. Mitochondrial alterations near amyloid plaques in an Alzheimer\u2019s disease mouse model. J Neurosci. 2013;33:17042\u201351.","journal-title":"J Neurosci"},{"key":"308_CR109","first-page":"89","volume":"65","author":"TR Mhyre","year":"2012","unstructured":"Mhyre TR, Boyd JT, Hamill RW, Maguire-Zeiss KA. Parkinson\u2019s Disease. Subcell Biochem. 2012;65:389\u2013455.","journal-title":"Subcell Biochem"},{"key":"308_CR110","doi-asserted-by":"publisher","first-page":"03","DOI":"10.3390\/biology9050103","volume":"9","author":"C V\u00e1radi","year":"2020","unstructured":"V\u00e1radi C. Clinical features of Parkinson\u2019s disease: the evolution of critical symptoms. Biology. 2020;9:03.","journal-title":"Biology"},{"key":"308_CR111","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fnmol.2018.00381","volume":"11","author":"S Sun","year":"2018","unstructured":"Sun S, Han X, Li X, Song Q, Lu M, Jia M, et al. MicroRNA-212-5p prevents dopaminergic neuron death by inhibiting SIRT2 in MPTP-induced mouse model of Parkinson\u2019s disease. Front Mol Neurosci. 2018;11:81.","journal-title":"Front Mol Neurosci"},{"key":"308_CR112","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0047-6374(99)00064-0","volume":"111","author":"M Naoi","year":"1999","unstructured":"Naoi M, Maruyama W. Cell death of dopamine neurons in aging and Parkinson\u2019s disease. Mech Ageing Dev. 1999;111:75\u2013188.","journal-title":"Mech Ageing Dev"},{"key":"308_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215277","volume":"14","author":"N Callizot","year":"2019","unstructured":"Callizot N, Combes M, Henriques A, Poindron P. Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins. PLoS ONE. 2019;14: e0215277.","journal-title":"PLoS ONE"},{"key":"308_CR114","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12035-012-8327-0","volume":"47","author":"T Yasuda","year":"2013","unstructured":"Yasuda T, Nakata Y, Mochizuki H. \u03b1-synuclein and neuronal cell death. Mol Neurobiol. 2013;47:466\u201383.","journal-title":"Mol Neurobiol"},{"key":"308_CR115","first-page":"049","volume":"26","author":"AH Schapira","year":"2011","unstructured":"Schapira AH, Jenner P. Etiology and pathogenesis of Parkinson\u2019s disease. Mov Disord Official J Mov Disord Soc. 2011;26:1049\u201355.","journal-title":"Mov Disord Official J Mov Disord Soc"},{"key":"308_CR116","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nm.2165","volume":"16","author":"JA Obeso","year":"2010","unstructured":"Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, et al. Missing pieces in the Parkinson\u2019s disease puzzle. Nat Med. 2010;16:653\u201361.","journal-title":"Nat Med"},{"key":"308_CR117","doi-asserted-by":"publisher","first-page":"09","DOI":"10.1038\/nrneurol.2010.52","volume":"6","author":"AHV Schapira","year":"2010","unstructured":"Schapira AHV, Tolosa E. Molecular and clinical prodrome of Parkinson disease: implications for treatment. Nat Rev Neurol. 2010;6:309\u201317.","journal-title":"Nat Rev Neurol"},{"key":"308_CR118","first-page":"30","volume":"124","author":"X Reed","year":"2018","unstructured":"Reed X, Bandr\u00e9s-Ciga S, Blauwendraat C, Cookson MR. The role of monogenic genes in idiopathic Parkinson\u2019s disease. Neurobiol Dis. 2018;124:230\u201339.","journal-title":"Neurobiol Dis"},{"key":"308_CR119","doi-asserted-by":"publisher","first-page":"091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18:1091\u2013102.","journal-title":"Lancet Neurol"},{"key":"308_CR120","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/mds.25249","volume":"28","author":"AB Singleton","year":"2013","unstructured":"Singleton AB, Farrer MJ, Bonifati V. The genetics of Parkinson\u2019s disease: progress and therapeutic implications: the genetics of PD. Movement Disord. 2013;28:4\u201323.","journal-title":"Movement Disord"},{"key":"308_CR121","first-page":"69","volume":"16","author":"MK McCoy","year":"2012","unstructured":"McCoy MK, Cookson MR. Mitochondrial quality control and dynamics in Parkinson\u2019s disease. Antioxid Redox Sign. 2012;16:869\u201382.","journal-title":"Antioxid Redox Sign"},{"key":"308_CR122","doi-asserted-by":"publisher","first-page":"03","DOI":"10.5607\/en.2015.24.2.103","volume":"24","author":"HE Moon","year":"2015","unstructured":"Moon HE, Paek SH. Mitochondrial dysfunction in Parkinson\u2019s disease. Exp Neurobiol. 2015;24:103\u201316.","journal-title":"Exp Neurobiol"},{"key":"308_CR123","doi-asserted-by":"publisher","first-page":"042","DOI":"10.1523\/JNEUROSCI.1384-17.2017","volume":"38","author":"M Pinto","year":"2018","unstructured":"Pinto M, Nissanka N, Moraes CT. Lack of Parkin anticipates the phenotype and affects mitochondrial morphology and mtDNA levels in a mouse model of Parkinson\u2019s disease. J Neurosci. 2018;38:1042\u201353.","journal-title":"J Neurosci"},{"key":"308_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2016.12.024","volume":"100","author":"L Song","year":"2017","unstructured":"Song L, McMackin M, Nguyen A, Cortopassi G. Parkin deficiency accelerates consequences of mitochondrial DNA deletions and Parkinsonism. Neurobiol Dis. 2017;100:1\u201338.","journal-title":"Neurobiol Dis"},{"key":"308_CR125","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12640-011-9259-6","volume":"21","author":"CJ Yong-Kee","year":"2012","unstructured":"Yong-Kee CJ, Sidorova E, Hanif A, Perera G, Nash JE. Mitochondrial dysfunction precedes other sub-cellular abnormalities in an in vitro model linked with cell death in Parkinson\u2019s disease. Neurotox Res. 2012;21:185\u201394.","journal-title":"Neurotox Res"},{"key":"308_CR126","first-page":"8","volume":"48\u201355","author":"N Bhattacharjee","year":"2016","unstructured":"Bhattacharjee N, Borah A. Oxidative stress and mitochondrial dysfunction are the underlying events of dopaminergic neurodegeneration in homocysteine rat model of Parkinson\u2019s disease. Neurochem Int. 2016;48\u201355:8\u201355.","journal-title":"Neurochem Int"},{"key":"308_CR127","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0006-291X(89)91141-8","volume":"163","author":"Y Mizuno","year":"1989","unstructured":"Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, et al. Deficiencies in Complex I subunits of the respiratory chain in Parkinson\u2019s disease. Biochem Biophys Res Commun. 1989;163:1450\u201355.","journal-title":"Biochem Biophys Res Commun"},{"key":"308_CR128","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ana.410300409","volume":"30","author":"N Hattori","year":"1991","unstructured":"Hattori N, Tanaka M, Ozawa T, Mizuno Y. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson\u2019s disease. Ann Neurol. 1991;30:563\u201371.","journal-title":"Ann Neurol"},{"key":"308_CR129","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1073\/pnas.0409713102","volume":"102","author":"F Fornai","year":"2005","unstructured":"Fornai F, Schluter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, et al. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and \u03b1-synuclein. Proc Natl Acad Sci U S A. 2005;102:3413\u201318.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"308_CR130","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1248\/bpb.34.92","volume":"34","author":"M Inden","year":"2011","unstructured":"Inden M, Kitamura Y, Abe M, Tamaki A, Takata K, Taniguchi T. Parkinsonian rotenone mouse model: reevaluation of long-term administration of rotenone in C57BL\/6 mice. Biol Pharm Bull. 2011;34:2\u201396.","journal-title":"Biol Pharm Bull"},{"key":"308_CR131","first-page":"1","volume":"211","author":"J Bov\u00e9","year":"2011","unstructured":"Bov\u00e9 J, Perier C. Neurotoxin-based models of Parkinson\u2019s disease. Neuroscience. 2011;211:1\u201376.","journal-title":"Neuroscience"},{"key":"308_CR132","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ana.24571","volume":"79","author":"A Gr\u00fcnewald","year":"2016","unstructured":"Gr\u00fcnewald A, Rygiel KA, Hepplewhite PD, Morris CM, Picard M, Turnbull DM. Mitochondrial DNA depletion in respiratory chain-deficient parkinson disease neurons. Ann Neurol. 2016;79:66\u201378.","journal-title":"Ann Neurol"},{"key":"308_CR133","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1038\/ncomms13548","volume":"7","author":"C D\u00f6lle","year":"2016","unstructured":"D\u00f6lle C, Fl\u00f8nes I, Nido GS, Miletic H, Osuagwu N, Kristoffersen S, et al. Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease. Nat Commun. 2016;7:3548.","journal-title":"Nat Commun"},{"key":"308_CR134","doi-asserted-by":"publisher","first-page":"05","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392:605\u20138.","journal-title":"Nature"},{"key":"308_CR135","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1086\/319522","volume":"68","author":"EM Valente","year":"2001","unstructured":"Valente EM, Bentivoglio AR, Dixon PH, Ferraris A, Ialongo T, Frontali M, et al. Localization of a novel locus for autosomal recessive early-onset Parkinsonism PARK6 on human chromosome 1p35-p36. Am J Hum Genetics. 2001;68:895\u2013900.","journal-title":"Am J Hum Genetics"},{"key":"308_CR136","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tins.2014.03.004","volume":"37","author":"LA Scarffe","year":"2014","unstructured":"Scarffe LA, Stevens DA, Dawson VL, Dawson TM. Parkin and PINK1: much more than mitophagy. Trends Neurosci. 2014;37:315\u201324.","journal-title":"Trends Neurosci"},{"key":"308_CR137","first-page":"94","volume":"17","author":"I Novak","year":"2012","unstructured":"Novak I. Mitophagy: a complex mechanism of mitochondrial removal. Antioxid Redox Sign. 2012;17:794\u2013802.","journal-title":"Antioxid Redox Sign"},{"key":"308_CR138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000298","volume":"8","author":"DP Narendra","year":"2010","unstructured":"Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, et al. PINK1 is selectively stabilized on impaired mitochondria to activate parkin. Plos Biol. 2010;8: e1000298.","journal-title":"Plos Biol"},{"key":"308_CR139","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1002\/mds.22798","volume":"25","author":"TM Dawson","year":"2010","unstructured":"Dawson TM, Dawson VL. The role of parkin in familial and sporadic Parkinson\u2019s disease. Movement Disord. 2010;25:S32\u20139.","journal-title":"Movement Disord"},{"key":"308_CR140","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells8070712","volume":"8","author":"J Liu","year":"2019","unstructured":"Liu J, Liu W, Li R, Yang H. Mitophagy in Parkinson\u2019s disease: from pathogenesis to treatment. Cells. 2019;8:12.","journal-title":"Cells"},{"key":"308_CR141","doi-asserted-by":"publisher","first-page":"8614","DOI":"10.1074\/jbc.M401135200","volume":"279","author":"JJ Palacino","year":"2004","unstructured":"Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, et al. Mitochondrial dysfunction and oxidative damage in parkin-deficient Mice. J Biol Chem. 2004;279:18614\u201322.","journal-title":"J Biol Chem"},{"key":"308_CR142","first-page":"1364","volume":"12","author":"CA Gautier","year":"2008","unstructured":"Gautier CA, Kitada T, Shen J. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A. 2008;12:1364\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"308_CR143","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/emmm.200900006","volume":"1","author":"VA Morais","year":"2009","unstructured":"Morais VA, Verstreken P, Roethig A, Smet J, Snellinx A, Vanbrabant M, et al. Parkinson\u2019s disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function. Embo Mol Med. 2009;1:109\u201311.","journal-title":"Embo Mol Med"},{"key":"308_CR144","doi-asserted-by":"publisher","first-page":"C164","DOI":"10.1152\/ajpcell.00064.2017","volume":"315","author":"N Peker","year":"2018","unstructured":"Peker N, Donipadi V, Sharma M, McFarlane C, Kambadur R. Loss of Parkin impairs mitochondrial function and leads to muscle atrophy. Am J Physiol. 2018;315:C164\u201385.","journal-title":"Am J Physiol"},{"key":"308_CR145","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.mcp.2016.11.001","volume":"30","author":"CM Lill","year":"2016","unstructured":"Lill CM. Genetics of Parkinson\u2019s disease. Mol Cell Probe. 2016;30:386\u201396.","journal-title":"Mol Cell Probe"},{"key":"308_CR146","doi-asserted-by":"publisher","first-page":"00","DOI":"10.1016\/j.tibs.2015.02.003","volume":"40","author":"BJ Ryan","year":"2015","unstructured":"Ryan BJ, Hoek S, Fon EA, Wade-Martins R. Mitochondrial dysfunction and mitophagy in Parkinson\u2019s: from familial to sporadic disease. Trends Biochem Sci. 2015;40:00\u201310.","journal-title":"Trends Biochem Sci"},{"key":"308_CR147","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat Genet. 2014;46:989\u201393.","journal-title":"Nat Genet"},{"key":"308_CR148","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.parkreldis.2005.05.004","volume":"11","author":"D Gosal","year":"2005","unstructured":"Gosal D, Ross OA, Wiley J, Irvine GB, Johnston JA, Toft M, et al. Clinical traits of LRRK2-associated Parkinson\u2019s disease in Ireland: A link between familial and idiopathic PD. Parkinsonism Relat D. 2005;11:349\u201352.","journal-title":"Parkinsonism Relat D"},{"key":"308_CR149","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nn1776","volume":"9","author":"WW Smith","year":"2006","unstructured":"Smith WW, Pei Z, Jiang H, Dawson VL, Dawson TM, Ross CA. Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci. 2006;9:1231\u20133.","journal-title":"Nat Neurosci"},{"key":"308_CR150","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2013.01.008","volume":"12","author":"P Reinhardt","year":"2013","unstructured":"Reinhardt P, Schmid B, Burbulla LF, Sch\u00f6ndorf DC, Wagner L, Glatza M, et al. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell. 2013;12:54\u201367.","journal-title":"Cell Stem Cell"},{"key":"308_CR151","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.nbd.2015.02.031","volume":"78","author":"M Yue","year":"2015","unstructured":"Yue M, Hinkle KM, Davies P, Trushina E, Fiesel FC, Christenson TA, et al. Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice. Neurobiol Dis. 2015;78:72\u201395.","journal-title":"Neurobiol Dis"},{"key":"308_CR152","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1212\/WNL.49.4.918","volume":"49","author":"RH Swerdlow","year":"1997","unstructured":"Swerdlow RH, Parks JK, Cassarino DS, Maguire DJ, Maguire RS, Bennett JP, et al. Cybrids in Alzheimer\u2019s disease: a cellular model of the disease? Neurology. 1997;49:918\u201325.","journal-title":"Neurology"},{"key":"308_CR153","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12035-014-8893-4","volume":"52","author":"D Santos","year":"2015","unstructured":"Santos D, Esteves AR, Silva DF, Janu\u00e1rio C, Cardoso SM. The impact of mitochondrial fusion and fission modulation in sporadic Parkinson\u2019s disease. Mol Neurobiol. 2015;52:573\u201386.","journal-title":"Mol Neurobiol"},{"key":"308_CR154","doi-asserted-by":"publisher","first-page":"04","DOI":"10.1111\/j.1471-4159.2012.07769.x","volume":"122","author":"W Xie","year":"2012","unstructured":"Xie W, Chung KKK. Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson\u2019s disease. J Neurochem. 2012;122:04\u201314.","journal-title":"J Neurochem"},{"key":"308_CR155","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/hmg\/dds311","volume":"21","author":"AH Pham","year":"2012","unstructured":"Pham AH, Meng S, Chu QN, Chan DC. Loss of Mfn2 results in progressive retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit. Hum Mol Genet. 2012;21:4817\u201326.","journal-title":"Hum Mol Genet"},{"key":"308_CR156","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1474-9726.2011.00721.x","volume":"10","author":"X Wang","year":"2011","unstructured":"Wang X, Su B, Liu W, He X, Gao Y, Castellani RJ, et al. DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson\u2019s disease. Aging Cell. 2011;10:817\u201323.","journal-title":"Aging Cell"},{"key":"308_CR157","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/cells10040885","volume":"10","author":"P Portz","year":"2021","unstructured":"Portz P, Lee MK. Changes in Drp1 function and mitochondrial morphology are associated with the \u03b1-synuclein pathology in a transgenic mouse model of Parkinson\u2019s disease. Cells. 2021;10:85.","journal-title":"Cells"},{"key":"308_CR158","doi-asserted-by":"publisher","first-page":"0710","DOI":"10.1074\/jbc.M110.213538","volume":"286","author":"K Nakamura","year":"2011","unstructured":"Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy JM, Egami K, et al. Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein \u03b1-synuclein. J Biol Chem. 2011;286:20710\u201326.","journal-title":"J Biol Chem"},{"key":"308_CR159","doi-asserted-by":"publisher","first-page":"04","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, et al. Huntington disease: natural history biomarkers and prospects for therapeutics. Nat Rev Neurol. 2014;10:204\u201316.","journal-title":"Nat Rev Neurol"},{"key":"308_CR160","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell. 1993;72:971\u201383.","journal-title":"Cell"},{"key":"308_CR161","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RAC Roos","year":"2010","unstructured":"Roos RAC. Huntington\u2019s disease- a clinical review. Orph J Rare Dis. 2010;5:40.","journal-title":"Orph J Rare Dis"},{"key":"308_CR162","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0092-8674(95)90542-1","volume":"81","author":"J Nasir","year":"1995","unstructured":"Nasir J, Floresco SB, O\u2019Kusky JR, Diewert VM, Richman JM, Zeisler J, et al. Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell. 1995;81:811\u201323.","journal-title":"Cell"},{"key":"308_CR163","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","volume":"20","author":"D Rigamonti","year":"2000","unstructured":"Rigamonti D, Bauer JH, De-Fraja C, Conti L, Sipione S, Sciorati C, et al. Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci. 2000;20:3705\u201313.","journal-title":"J Neurosci"},{"key":"308_CR164","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.nbd.2005.12.007","volume":"22","author":"DTW Chang","year":"2006","unstructured":"Chang DTW, Rintoul GL, Pandipati S, Reynolds IJ. Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol Dis. 2006;22:388\u2013400.","journal-title":"Neurobiol Dis"},{"key":"308_CR165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2008.03.010","volume":"31","author":"H Zhang","year":"2008","unstructured":"Zhang H, Li Q, Graham RK, Slow E, Hayden MR, Bezprozvanny I. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington\u2019s disease. Neurobiol Dis. 2008;31:81\u201388.","journal-title":"Neurobiol Dis"},{"key":"308_CR166","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-1326-8-45","volume":"8","author":"RA Quintanilla","year":"2013","unstructured":"Quintanilla RA, Jin YN, von Bernhardi R, Johnson GV. Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease. Mol Neurodegener. 2013;8:5\u201345.","journal-title":"Mol Neurodegener"},{"key":"308_CR167","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.pneurobio.2006.11.003","volume":"81","author":"MMY Fan","year":"2007","unstructured":"Fan MMY, Raymond LA. N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington\u2019s disease. Prog Neurobiol. 2007;81:72\u201393.","journal-title":"Prog Neurobiol"},{"key":"308_CR168","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neuron.2005.06.005","volume":"47","author":"BI Bae","year":"2005","unstructured":"Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N, Taya Y, et al. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington\u2019s disease. Neuron. 2005;47:29\u201341.","journal-title":"Neuron"},{"key":"308_CR169","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1074\/jbc.M603845200","volume":"281","author":"T Milakovic","year":"2006","unstructured":"Milakovic T, Quintanilla RA, Johnson GVW. Mutant Huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells. J Biol Chem. 2006;281:34785\u201395.","journal-title":"J Biol Chem"},{"key":"308_CR170","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/hmg\/ddh162","volume":"13","author":"YS Choo","year":"2004","unstructured":"Choo YS, Johnson GVW, MacDonald M, Detloff PJ, Lesort M. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet. 2004;13:1407\u201320.","journal-title":"Hum Mol Genet"},{"key":"308_CR171","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/hmg\/ddq306","volume":"19","author":"J Kim","year":"2010","unstructured":"Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, et al. Mitochondrial loss dysfunction and altered dynamics in Huntington\u2019s disease. Hum Mol Genet. 2010;19:3919\u201335.","journal-title":"Hum Mol Genet"},{"key":"308_CR172","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/hmg\/ddr024","volume":"20","author":"U Shirendeb","year":"2011","unstructured":"Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, Tagle DA, et al. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage. Hum Mol Genet. 2011;20:1438\u201355.","journal-title":"Hum Mol Genet"},{"key":"308_CR173","first-page":"19","volume":"507","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Sun X, Qi X. Inhibition of Drp1 hyperactivation reduces neuropathology and behavioral deficits in zQ175 knock-in mouse model of Huntington\u2019s disease. Biochem Bioph Res. 2018;507:319\u201323.","journal-title":"Biochem Bioph Res"},{"key":"308_CR174","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","volume":"28","author":"AL Orr","year":"2008","unstructured":"Orr AL, Li S, Wang CE, Li H, Wang J, Rong J, et al. N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci. 2008;28:2783\u201392.","journal-title":"J Neurosci"},{"key":"308_CR175","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1471-4159.1998.70020794.x","volume":"70","author":"E Brouillet","year":"1998","unstructured":"Brouillet E, Guyot M, Mittoux V, Altairac S, Cond\u00e9 F, Palfi S, et al. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem. 1998;70:794\u2013805.","journal-title":"J Neurochem"},{"key":"308_CR176","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1091\/mbc.e05-07-0607","volume":"17","author":"A Benchoua","year":"2006","unstructured":"Benchoua A, Trioulier Y, Zala D, Gaillard MC, Lefort N, Dufour N, et al. Involvement of Mitochondrial Complex II defects in neuronal death produced by N-terminus fragment of mutated Huntingtin. Mol Biol Cell. 2006;17:1652\u201363.","journal-title":"Mol Biol Cell"},{"key":"308_CR177","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","volume":"44","author":"WA Brennan","year":"1985","unstructured":"Brennan WA, Bird ED, Aprille JR. Regional mitochondrial respiratory activity in Huntington\u2019s disease brain. J Neurochem. 1985;44:1948\u201350.","journal-title":"J Neurochem"},{"key":"308_CR178","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AHV. Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Ann Neurol. 1996;39:385\u201389.","journal-title":"Ann Neurol"},{"key":"308_CR179","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/ana.410410514","volume":"41","author":"SE Browne","year":"1997","unstructured":"Browne SE, Bowling AC, Macgarvey U, Baik MJ, Berger SC, Muquit MMK, et al. Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia. Ann Neurol. 1997;41:646\u201353.","journal-title":"Ann Neurol"},{"key":"308_CR180","first-page":"55","volume":"21","author":"GD Borasio","year":"2001","unstructured":"Borasio GD, Miller RG. Clinical characteristics and management of ALS. Semin Neuros. 2001;21:55\u201366.","journal-title":"Semin Neuros"},{"key":"308_CR181","first-page":"25","volume":"138","author":"EO Talbott","year":"2016","unstructured":"Talbott EO, Malek AM, Lacomis D. Chapter 13 The epidemiology of amyotrophic lateral sclerosis. Handb Clin Neurol. 2016;138:225\u201338.","journal-title":"Handb Clin Neurol"},{"key":"308_CR182","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000085063","volume":"1","author":"L Dupuis","year":"2004","unstructured":"Dupuis L, Gonzalez de Aguilar JL, Oudart H, de Tapia M, Barbeito L, Loeffler JP. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target. Neurodegener Dis. 2004;1:245\u201354.","journal-title":"Neurodegener Dis"},{"key":"308_CR183","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/hmg\/ddx348","volume":"26","author":"A Moller","year":"2017","unstructured":"Moller A, Bauer CS, Cohen RN, Webster CP, Vos KJD. Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels. Hum Mol Genet. 2017;26:4668\u201379.","journal-title":"Hum Mol Genet"},{"key":"308_CR184","first-page":"720","volume":"16","author":"KJD Vos","year":"2007","unstructured":"Vos KJD, Chapman AL, Tennant ME, Manser C, Tudor EL, Lau KF, et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum Mol Genet. 2007;16:2720\u201328.","journal-title":"Hum Mol Genet"},{"key":"308_CR185","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/hmg\/ddt528","volume":"23","author":"J Magran\u00e9","year":"2014","unstructured":"Magran\u00e9 J, Cortez C, Gan WB, Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum Mol Genet. 2014;23:1413\u201324.","journal-title":"Hum Mol Genet"},{"key":"308_CR186","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00401-020-02252-5","volume":"141","author":"AR Mehta","year":"2021","unstructured":"Mehta AR, Gregory JM, Dando O, Carter RN, Burr K, Nanda J, et al. Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis. Acta Neuropathol. 2021;141:257\u201379.","journal-title":"Acta Neuropathol"},{"key":"308_CR187","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/mus.21049","volume":"38","author":"FL Muller","year":"2008","unstructured":"Muller FL, Liu Y, Jernigan A, Borchelt D, Richardson A, Remmen HV. MnSOD deficiency has a differential effect on disease progression in two different ALS mutant mouse models. Muscle Nerve. 2008;38:1173\u201383.","journal-title":"Muscle Nerve"},{"key":"308_CR188","doi-asserted-by":"publisher","first-page":"81950","DOI":"10.3389\/fncel.2020.581950","volume":"14","author":"CJ Jagaraj","year":"2021","unstructured":"Jagaraj CJ, Parakh S, Atkin JD. Emerging evidence highlighting the importance of redox dysregulation in the pathogenesis of amyotrophic lateral sclerosis (ALS). Front Cell Neurosci. 2021;14:81950.","journal-title":"Front Cell Neurosci"},{"key":"308_CR189","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022031","volume":"6","author":"CV Velde","year":"2011","unstructured":"Velde CV, McDonald KK, Boukhedimi Y, McAlonis-Downes M, Lobsiger CS, Hadj SB, et al. Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset. PLoS ONE. 2011;6: e22031.","journal-title":"PLoS ONE"},{"key":"308_CR190","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/hmg\/ddp421","volume":"18","author":"J Magran\u00e9","year":"2009","unstructured":"Magran\u00e9 J, Hervias I, Henning MS, Damiano M, Kawamata H, Manfredi G. Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities. Hum Mol Genet. 2009;18:4552\u201364.","journal-title":"Hum Mol Genet"},{"key":"308_CR191","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.nbd.2012.07.004","volume":"51","author":"W Song","year":"2013","unstructured":"Song W, Song Y, Kincaid B, Bossy B, Bossy-Wetzel E. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: Neuroprotection by SIRT3 and PGC-1\u03b1. Neurobiol Dis. 2013;51:72\u201381.","journal-title":"Neurobiol Dis"},{"key":"308_CR192","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082112","volume":"8","author":"G Luo","year":"2013","unstructured":"Luo G, Yi J, Ma C, Xiao Y, Yi F, Yu T, et al. Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model. PLoS ONE. 2013;8: e82112.","journal-title":"PLoS ONE"},{"key":"308_CR193","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40035-015-0037-x","volume":"4","author":"Z Jiang","year":"2015","unstructured":"Jiang Z, Wang W, Perry G, Zhu X, Wang X. Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis. Transl Neurodegener. 2015;4:4.","journal-title":"Transl Neurodegener"},{"key":"308_CR194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/nen.0b013e31802c396b","volume":"66","author":"S Sasaki","year":"2007","unstructured":"Sasaki S, Iwata M. Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2007;66:10\u201316.","journal-title":"J Neuropathol Exp Neurol"},{"key":"308_CR195","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1523\/JNEUROSCI.5385-12.2013","volume":"33","author":"W Tan","year":"2013","unstructured":"Tan W, Naniche N, Bogush A, Pedrini S, Trotti D, Pasinelli P. Small peptides against the mutant SOD1\/Bcl-2 toxic mitochondrial complex restore mitochondrial function and cell viability in mutant SOD1-mediated ALS. J Neurosci. 2013;33:11588\u201398.","journal-title":"J Neurosci"},{"key":"308_CR196","doi-asserted-by":"publisher","first-page":"9626","DOI":"10.1074\/jbc.M203065200","volume":"277","author":"M Mattiazzi","year":"2002","unstructured":"Mattiazzi M, D\u2019Aurelio M, Gajewski CD, Martushova K, Kiaei M, Beal MF, et al. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol Chem. 2002;277:29626\u201333.","journal-title":"J Biol Chem"},{"key":"308_CR197","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.abb.2019.01.024","volume":"663","author":"J Zhou","year":"2019","unstructured":"Zhou J, Li A, Li X, Yi J. Dysregulated mitochondrial Ca2+ and ROS signaling in skeletal muscle of ALS mouse model. Arch Biochem Biophys. 2019;663:249\u201358.","journal-title":"Arch Biochem Biophys"},{"key":"308_CR198","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/hmg\/ddt319","volume":"22","author":"W Wang","year":"2013","unstructured":"Wang W, Li L, Lin WL, Dickson DW, Petrucelli L, Zhang T, et al. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum Mol Genet. 2013;22:4706\u201319.","journal-title":"Hum Mol Genet"},{"key":"308_CR199","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/0304-3940(95)12039-7","volume":"199","author":"K Abe","year":"1995","unstructured":"Abe K, Pan LH, Watanabe M, Kato T, Itoyama Y. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci Lett. 1995;199:152\u20134.","journal-title":"Neurosci Lett"},{"key":"308_CR200","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/01616412.1997.11740784","volume":"19","author":"K Abe","year":"1997","unstructured":"Abe K, Pan LH, Watanabe M, Konno H, Kato T, Itoyama Y. Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurol Res. 1997;19:124\u20138.","journal-title":"Neurol Res"},{"key":"308_CR201","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/biom11030437","volume":"11","author":"P Hemerkov\u00e1","year":"2021","unstructured":"Hemerkov\u00e1 P, Vali\u0161 M. Role of oxidative stress in the pathogenesis of amyotrophic lateral sclerosis: antioxidant metalloenzymes and therapeutic strategies. Biomolecule. 2021;11:37.","journal-title":"Biomolecule"},{"key":"308_CR202","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/hmg\/ddq383","volume":"19","author":"A Ferri","year":"2010","unstructured":"Ferri A, Fiorenzo P, Nencini M, Cozzolino M, Pesaresi MG, Valle C, et al. Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity. Hum Mol Genet. 2010;19:4529\u201342.","journal-title":"Hum Mol Genet"},{"key":"308_CR203","doi-asserted-by":"publisher","first-page":"4670","DOI":"10.1073\/pnas.0903563106","volume":"106","author":"J Yao","year":"2009","unstructured":"Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. Mitochondrial bioenergetic deficit precedes Alzheimer\u2019s pathology in female mouse model of Alzheimer\u2019s disease. Proc National Acad Sci U S A. 2009;106:14670\u201375.","journal-title":"Proc National Acad Sci U S A"},{"key":"308_CR204","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11064-005-9236-7","volume":"31","author":"P Hoyo","year":"2006","unstructured":"Hoyo P, del Garc\u00eda-Redondo A, Bustos F, de Molina JA, Sayed Y, Alonso-Navarro H, Caballero L, Arenas J, et al. Oxidative stress in skin fibroblasts cultures of patients with Huntington\u2019s disease. Neurochem Res. 2006;31:1103\u20139.","journal-title":"Neurochem Res"},{"key":"308_CR205","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861\u201372.","journal-title":"Cell"},{"key":"308_CR206","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.celrep.2018.04.105","volume":"23","author":"Y Kim","year":"2018","unstructured":"Kim Y, Zheng X, Ansari Z, Bunnell MC, Herdy JR, Traxler L, et al. Mitochondrial aging defects emerge in directly reprogrammed human neurons due to their metabolic profile. Cell Rep. 2018;23:2550\u20138.","journal-title":"Cell Rep"},{"key":"308_CR207","doi-asserted-by":"publisher","first-page":"000","DOI":"10.1016\/j.stemcr.2014.10.007","volume":"3","author":"C Heinrich","year":"2014","unstructured":"Heinrich C, Bergami M, Gasc\u00f3n S, Lepier A, Vigan\u00f2 F, Dimou L, et al. Sox2-mediated conversion of NG2 glia into induced neurons in the injured adult cerebral cortex. Stem Cell Rep. 2014;3:1000\u201314.","journal-title":"Stem Cell Rep"},{"key":"308_CR208","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41593-018-0075-7","volume":"21","author":"MB Victor","year":"2018","unstructured":"Victor MB, Richner M, Olsen HE, Lee SW, Monteys AM, Ma C, et al. Striatal neurons directly converted from Huntington\u2019s disease patient fibroblasts recapitulate age-associated disease phenotypes. Nat Neurosci. 2018;21:341\u201352.","journal-title":"Nat Neurosci"},{"key":"308_CR209","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41593-020-00714-3","volume":"23","author":"MB Victor","year":"2020","unstructured":"Victor MB, Richner M, Olsen HE, Lee SW, Monteys AM, Ma C, et al. Author Correction: Striatal neurons directly converted from Huntington\u2019s disease patient fibroblasts recapitulate age-associated disease phenotypes. Nat Neurosci. 2020;23:1307.","journal-title":"Nat Neurosci"},{"key":"308_CR210","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrd.2016.245","volume":"16","author":"Y Shi","year":"2017","unstructured":"Shi Y, Inoue H, Wu JC, Yamanaka S. Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov. 2017;16:115\u201330.","journal-title":"Nat Rev Drug Discov"},{"key":"308_CR211","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nbt.2014.05.001","volume":"32","author":"NL Payne","year":"2015","unstructured":"Payne NL, Sylvain A, O\u2019Brien C, Herszfeld D, Sun G, Bernard CCA. Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases. New Biotechnol. 2015;32:212\u201328.","journal-title":"New Biotechnol"},{"key":"308_CR212","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.1218071","volume":"338","author":"SA Goldman","year":"2012","unstructured":"Goldman SA, Nedergaard M, Windrem MS. Glial progenitor cell\u2013based treatment and modeling of neurological disease. Science. 2012;338:491\u20135.","journal-title":"Science"},{"key":"308_CR213","first-page":"169","volume":"29","author":"JT Dimos","year":"2008","unstructured":"Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008;29:169\u201370.","journal-title":"Science"},{"key":"308_CR214","first-page":"65431","volume":"1866","author":"X Zhang","year":"2019","unstructured":"Zhang X, Hu D, Shang Y, Qi X. Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases. Biochim Biophys Acta Mol Basis Dis. 2019;1866:65431.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"308_CR215","doi-asserted-by":"publisher","first-page":"e2696","DOI":"10.1038\/cddis.2017.89","volume":"8","author":"VC Jones","year":"2017","unstructured":"Jones VC, Atkinson-Dell R, Verkhratsky A, Mohamet L. Aberrant iPSC-derived human astrocytes in Alzheimer\u2019s disease. Cell Death Dis. 2017;8:e2696\u2013e2696.","journal-title":"Cell Death Dis"},{"key":"308_CR216","first-page":"48","volume":"25","author":"J Penney","year":"2019","unstructured":"Penney J, Ralvenius WT, Tsai LH. Modeling Alzheimer\u2019s disease with iPSC-derived brain cells. Mol Psychiatr. 2019;25:148\u201367.","journal-title":"Mol Psychiatr"},{"key":"308_CR217","doi-asserted-by":"publisher","first-page":"02362","DOI":"10.1016\/j.ceca.2021.102362","volume":"94","author":"M Trombetta-Lima","year":"2021","unstructured":"Trombetta-Lima M, Sabogal-Gu\u00e1queta AM, Dolga AM. Mitochondrial dysfunction in neurodegenerative diseases: a focus on iPSC-derived neuronal models. Cell Calcium. 2021;94:02362.","journal-title":"Cell Calcium"},{"key":"308_CR218","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-016-0228-4","volume":"9","author":"C Arber","year":"2017","unstructured":"Arber C, Lovejoy C, Wray S. Stem cell models of Alzheimer\u2019s disease: progress and challenges. Alzheimer\u2019s Res Ther. 2017;9:2.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"308_CR219","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/hmg\/ddr394","volume":"20","author":"T Yagi","year":"2011","unstructured":"Yagi T, Ito D, Okada Y, Akamatsu W, Nihei Y, Yoshizaki T. Modeling familial Alzheimer\u2019s disease with induced pluripotent stem cells. Hum Mol Genet. 2011;20:530\u20139.","journal-title":"Hum Mol Genet"},{"key":"308_CR220","doi-asserted-by":"publisher","first-page":"e84547","DOI":"10.1371\/journal.pone.0084547","volume":"9","author":"AA Sproul","year":"2014","unstructured":"Sproul AA, Jacob S, Pre D, Kim SH, Nestor MW, Navarro-Sobrino M, et al. Characterization and molecular profiling of PSEN1 familial Alzheimer\u2019s disease iPSC-derived neural progenitors. PLoS ONE. 2014;9:e84547.","journal-title":"PLoS ONE"},{"key":"308_CR221","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/nature10821","volume":"482","author":"MA Israel","year":"2012","unstructured":"Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, et al. Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells. Nature. 2012;482:16\u2013220.","journal-title":"Nature"},{"key":"308_CR222","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.brainres.2018.06.010","volume":"1702","author":"A Singh","year":"2019","unstructured":"Singh A, Zhi L, Zhang H. LRRK2 and mitochondria: recent advances and current views. Brain Res. 2019;1702:6\u2013104.","journal-title":"Brain Res"},{"key":"308_CR223","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.celrep.2018.05.009","volume":"23","author":"DC Sch\u00f6ndorf","year":"2018","unstructured":"Sch\u00f6ndorf DC, Ivanyuk D, Baden P, Sanchez-Martinez A, Cicco SD, Yu C, et al. The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson\u2019s disease. Cell Rep. 2018;23:2976\u201388.","journal-title":"Cell Rep"},{"key":"308_CR224","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/scrt173","volume":"4","author":"X Zeng","year":"2013","unstructured":"Zeng X, Couture LA. Pluripotent stem cells for Parkinson\u2019s disease: progress and challenges. Stem Cell Res Ther. 2013;4:5.","journal-title":"Stem Cell Res Ther"},{"key":"308_CR225","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cell.2008.07.041","volume":"134","author":"IH Park","year":"2008","unstructured":"Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, et al. Disease-specific induced pluripotent stem cells. Cell. 2008;134:877\u201386.","journal-title":"Cell"},{"key":"308_CR226","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2011.12.042","volume":"46","author":"S Camnasio","year":"2012","unstructured":"Camnasio S, Carri AD, Lombardo A, Grad I, Mariotti C, Castucci A, et al. The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington\u2019s disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol Dis. 2012;46:41\u201351.","journal-title":"Neurobiol Dis"},{"key":"308_CR227","doi-asserted-by":"publisher","first-page":"RRN1193","DOI":"10.1371\/currents.RRN1193","volume":"2","author":"N Zhang","year":"2010","unstructured":"Zhang N, An MC, Montoro D, Ellerby LM. Characterization of human Huntington\u2019s disease cell model from induced pluripotent stem cells. PLoS Curr. 2010;2:RRN1193.","journal-title":"PLoS Curr."},{"key":"308_CR228","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/hmg\/ddv080","volume":"24","author":"VB Mattis","year":"2015","unstructured":"Mattis VB, Tom C, Akimov S, Saeedian J, \u00d8stergaard ME, Southwell AL, Doty CN, Ornelas L, Sahabian A, Lenaeus L, et al. HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity. Hum Mol Genet. 2015;24:3257\u201371.","journal-title":"Hum Mol Genet"},{"key":"308_CR229","doi-asserted-by":"publisher","first-page":"76592","DOI":"10.3389\/fcell.2020.576592","volume":"8","author":"C Lopes","year":"2020","unstructured":"Lopes C, Tang Y, Anjo SI, Manadas B, Onofre I, Almeida LP, et al. Mitochondrial and redox modifications in huntington disease induced pluripotent stem cells rescued by CRISPR\/Cas9 CAGs targeting. Front Cell Dev Biol. 2020;8:76592.","journal-title":"Front Cell Dev Biol"},{"key":"308_CR230","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/hmg\/ddy430","volume":"29","author":"HD iPSC Consortium","year":"2020","unstructured":"HD iPSC Consortium. Bioenergetic deficits in Huntington\u2019s disease iPSC-derived neural cells and rescue with glycolytic metabolites. Hum Mol Genet. 2020;29:1757\u201371.","journal-title":"Hum Mol Genet"},{"key":"308_CR231","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1523\/JNEUROSCI.0906-12.2013","volume":"33","author":"MW Amoroso","year":"2013","unstructured":"Amoroso MW, Croft GF, Williams DJ, O\u2019Keeffe S, Carrasco MA, Davis AR, et al. Accelerated high-yield generation of limb-innervating motor neurons from human stem cells. J Neurosci. 2013;33:74\u201386.","journal-title":"J Neurosci"},{"key":"308_CR232","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/ncomms4449","volume":"5","author":"Q Qu","year":"2014","unstructured":"Qu Q, Li D, Louis KR, Li X, Yang H, Sun Q, et al. High-efficiency motor neuron differentiation from human pluripotent stem cells and the function of Islet-1. Nat Commun. 2014;5:449.","journal-title":"Nat Commun"},{"key":"308_CR233","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.stem.2014.02.004","volume":"14","author":"H Chen","year":"2014","unstructured":"Chen H, Qian K, Du Z, Cao J, Petersen A, Liu H, et al. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell. 2014;14:796\u2013809.","journal-title":"Cell Stem Cell"},{"key":"308_CR234","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1126\/science.1158799","volume":"321","author":"JT Dimos","year":"2008","unstructured":"Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008;321:1218\u201321.","journal-title":"Science"},{"key":"308_CR235","first-page":"77","volume":"457","author":"AD Ebert","year":"2008","unstructured":"Ebert AD, Yu J, Rose FF, Mattis VB, Lorson CL, Thomson JA, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2008;457:277\u201380.","journal-title":"Nature"},{"key":"308_CR236","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1073\/pnas.1202922109","volume":"109","author":"B Bilican","year":"2012","unstructured":"Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan GJ, Carrasco M, et al. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci U S A. 2012;109:803\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"308_CR237","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.neurobiolaging.2013.11.025","volume":"35","author":"SP Allen","year":"2014","unstructured":"Allen SP, Rajan S, Duffy L, Mortiboys H, Higginbottom A, Grierson AJ, et al. Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis. Neurobiol Aging. 2014;35:1499\u2013509.","journal-title":"Neurobiol Aging"},{"key":"308_CR238","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s12035-012-8277-6","volume":"45","author":"AI Abdullah","year":"2012","unstructured":"Abdullah AI, Pollock A, Sun T. The path from skin to brain: generation of functional neurons from fibroblasts. Mol Neurobiol. 2012;45:586\u201395.","journal-title":"Mol Neurobiol"},{"key":"308_CR239","doi-asserted-by":"crossref","unstructured":"Jiang H, Ren Y, Yuen EY, Zhong P, Ghaedi M, Hu Z, et al. Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nat Commun. 2012;7:18.","DOI":"10.1038\/ncomms1669"},{"key":"308_CR240","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/ncomms1669","volume":"3","author":"H Jiang","year":"2012","unstructured":"Jiang H, Ren Y, Yuen EY, Zhong P, Ghaedi M, Hu Z, et al. Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nat Commun. 2012;3:68.","journal-title":"Nat Commun"},{"key":"308_CR241","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCRESAHA.111.249235","volume":"112","author":"T Ma","year":"2013","unstructured":"Ma T, Xie M, Laurent T, Ding S. Progress in the reprogramming of somatic cells. Circ Res. 2013;112:62\u201374.","journal-title":"Circ Res"},{"key":"308_CR242","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.stem.2015.01.013","volume":"16","author":"J Xu","year":"2015","unstructured":"Xu J, Du Y, Deng H. Direct Lineage reprogramming: strategies mechanisms and applications. Cell Stem Cell. 2015;16:119\u201334.","journal-title":"Cell Stem Cell"},{"key":"308_CR243","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrn.2016.46","volume":"17","author":"J Mertens","year":"2016","unstructured":"Mertens J, Marchetto MC, Bardy C, Gage FH. Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. Nat Rev Neurosci. 2016;17:24\u201337.","journal-title":"Nat Rev Neurosci"},{"key":"308_CR244","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12035-018-1151-4","volume":"56","author":"TT Htike","year":"2019","unstructured":"Htike TT, Mishra S, Kumar S, Padmanabhan P, Guly\u00e1s B. Peripheral biomarkers for early detection of Alzheimer\u2019s and Parkinson\u2019s diseases. Mol Neurobiol. 2019;56:2256\u201377.","journal-title":"Mol Neurobiol"},{"key":"308_CR245","doi-asserted-by":"publisher","first-page":"043","DOI":"10.4103\/1673-5374.282257","volume":"15","author":"J Riancho","year":"2020","unstructured":"Riancho J, Arozamena S, Muna\u00edn AL. de Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis. Neural Regen Res. 2020;15:043.","journal-title":"Neural Regen Res"},{"key":"308_CR246","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.biocel.2006.11.005","volume":"39","author":"RJ McAnulty","year":"2007","unstructured":"McAnulty RJ. Fibroblasts and myofibroblasts: Their source, function and role in disease. Int J Biochem Cell Biol. 2007;39:666\u201371.","journal-title":"Int J Biochem Cell Biol"},{"key":"308_CR247","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1096\/fj.201903188R","volume":"34","author":"VS LeBleu","year":"2020","unstructured":"LeBleu VS, Neilson EG. Origin and functional heterogeneity of fibroblasts. Faseb J. 2020;34:3519\u201336.","journal-title":"Faseb J"},{"key":"308_CR248","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/wound.2014.0561","volume":"5","author":"LE Tracy","year":"2016","unstructured":"Tracy LE, Minasian RA, Caterson EJ. Extracellular matrix and dermal fibroblast function in the healing wound. Adv Wound Care. 2016;5:119\u201336.","journal-title":"Adv Wound Care"},{"key":"308_CR249","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13578-020-00476-2","volume":"10","author":"Z Xu","year":"2020","unstructured":"Xu Z, Su S, Zhou S, Yang W, Deng X, Sun Y, et al. How to reprogram human fibroblasts to neurons. Cell Biosci. 2020;10:16.","journal-title":"Cell Biosci"},{"key":"308_CR250","doi-asserted-by":"publisher","first-page":"04","DOI":"10.1016\/j.stem.2015.07.006","volume":"17","author":"W Hu","year":"2015","unstructured":"Hu W, Qiu B, Guan W, Wang Q, Wang M, Li W, et al. Direct conversion of normal and Alzheimer\u2019s disease human fibroblasts into neuronal cells by small molecules. Cell Stem Cell. 2015;17:204\u201312.","journal-title":"Cell Stem Cell"},{"key":"308_CR251","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.stem.2012.02.021","volume":"10","author":"DW Han","year":"2012","unstructured":"Han DW, Tapia N, Hermann A, Hemmer K, H\u00f6ing S, Ara\u00fazo-Bravo MJ, et al. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell. 2012;10:465\u201372.","journal-title":"Cell Stem Cell"},{"key":"308_CR252","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/15384101.2015.1060382","volume":"14","author":"H Xu","year":"2015","unstructured":"Xu H, Wang Y, He Z, Yang H, Gao WQ. Direct conversion of mouse fibroblasts to GABAergic neurons with combined medium without the introduction of transcription factors or miRNAs. Cell Cycle. 2015;14:2451\u201360.","journal-title":"Cell Cycle"},{"key":"308_CR253","doi-asserted-by":"publisher","first-page":"06","DOI":"10.1016\/j.redox.2017.01.009","volume":"11","author":"Z Xu","year":"2017","unstructured":"Xu Z, Chu X, Jiang H, Schilling H, Chen S, Feng J. Induced dopaminergic neurons: a new promise for Parkinson\u2019s disease. Redox Biol. 2017;11:606\u201312.","journal-title":"Redox Biol"},{"key":"308_CR254","doi-asserted-by":"publisher","first-page":"04545","DOI":"10.1016\/j.nbd.2019.104545","volume":"132","author":"LF Burbulla","year":"2019","unstructured":"Burbulla LF, Krainc D. The role of dopamine in the pathogenesis of GBA1-linked Parkinson\u2019s disease. Neurobiol Dis. 2019;132:04545.","journal-title":"Neurobiol Dis"},{"key":"308_CR255","first-page":"16","volume":"1707","author":"EA Giovannetti","year":"2018","unstructured":"Giovannetti EA, Fuhrmann M. Unsupervised excitation: GABAergic dysfunctions in Alzheimer\u2019s disease. Brain Res. 2018;1707:216\u201326.","journal-title":"Brain Res"},{"key":"308_CR256","doi-asserted-by":"publisher","first-page":"e00076","DOI":"10.1042\/AN20110031","volume":"4","author":"KA Hosie","year":"2012","unstructured":"Hosie KA, King AE, Blizzard CA, Vickers JC, Dickson TC. Chronic excitotoxin-induced axon degeneration in a compartmented neuronal culture model. ASN Neuro. 2012;4:e00076.","journal-title":"ASN Neuro"},{"key":"308_CR257","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.stem.2011.11.015","volume":"9","author":"N Yang","year":"2011","unstructured":"Yang N, Ng YH, Pang ZP, S\u00fcdhof TC, Wernig M. Induced neuronal cells: how to make and define a neuron. Cell Stem Cell. 2011;9:17\u201325.","journal-title":"Cell Stem Cell"},{"key":"308_CR258","doi-asserted-by":"publisher","first-page":"8290","DOI":"10.1038\/srep38290","volume":"6","author":"U Pfisterer","year":"2016","unstructured":"Pfisterer U, Ek F, Lang S, Soneji S, Olsson R, Parmar M. Small molecules increase direct neural conversion of human fibroblasts. Sci Rep. 2016;6:8290.","journal-title":"Sci Rep"},{"key":"308_CR259","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3892\/mmr.2020.11559","volume":"22","author":"J Yang","year":"2020","unstructured":"Yang J, Cao H, Guo S, Zhu H, Tao H, Zhang L, et al. Small molecular compounds efficiently convert human fibroblasts directly into neurons. Mol Med Rep. 2020;22:4763\u201371.","journal-title":"Mol Med Rep"},{"key":"308_CR260","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3164\/jcbn.15-39","volume":"56","author":"P Dai","year":"2015","unstructured":"Dai P, Harada Y, Takamatsu T. Highly efficient direct conversion of human fibroblasts to neuronal cells by chemical compounds. J Clin Biochem Nutr. 2015;56:166\u201370.","journal-title":"J Clin Biochem Nutr"},{"key":"308_CR261","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.52069","volume":"9","author":"H Lee","year":"2020","unstructured":"Lee H, Lee HY, Lee BE, Gerovska D, Park SY, Zaehres H, et al. Sequentially induced motor neurons from human fibroblasts facilitate locomotor recovery in a rodent spinal cord injury model. Elife. 2020;9: e52069.","journal-title":"Elife"},{"key":"308_CR262","doi-asserted-by":"crossref","unstructured":"Clos AL, Kayed R, Lasagna-Reeves CA. Association of skin with the pathogenesis and treatment of neurodegenerative amyloidosis. Front Neurol. 2012;3.","DOI":"10.3389\/fneur.2012.00005"},{"key":"308_CR263","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1073\/pnas.88.1.16","volume":"88","author":"MJ Adler","year":"1991","unstructured":"Adler MJ, Coronel C, Shelton E, Seegmiller JE, Dewji NN. Increased gene expression of Alzheimer disease beta-amyloid precursor protein in senescent cultured fibroblasts. Proc National Acad Sci U S A. 1991;88:16\u201320.","journal-title":"Proc National Acad Sci U S A"},{"key":"308_CR264","doi-asserted-by":"publisher","first-page":"C641","DOI":"10.1152\/ajpcell.00222.2006","volume":"292","author":"O Kann","year":"2007","unstructured":"Kann O, Kov\u00e1cs R. Mitochondria and neuronal activity. Am J Physiol. 2007;292:C641\u201357.","journal-title":"Am J Physiol"},{"key":"308_CR265","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/aps.2017.183","volume":"39","author":"S Rajasingh","year":"2018","unstructured":"Rajasingh S, Isai DG, Samanta S, Zhou ZG, Dawn B, Kinsey WH, et al. Manipulation-free cultures of human iPSC-derived cardiomyocytes offer a novel screening method for cardiotoxicity. Acta Pharmacol Sin. 2018;39:1590\u2013603.","journal-title":"Acta Pharmacol Sin"},{"key":"308_CR266","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature23664","volume":"548","author":"T Kikuchi","year":"2017","unstructured":"Kikuchi T, Morizane A, Doi D, Magotani H, Onoe H, Hayashi T, et al. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model. Nature. 2017;548:592\u201396.","journal-title":"Nature"},{"key":"308_CR267","doi-asserted-by":"crossref","unstructured":"Jr WDP, Parks J, Filley CM, Kleinschmidt-DeMasters BK. Electron transport chain defects in Alzheimer\u2019s disease brain. Neurology. 1994;44:1090\u20136.","DOI":"10.1212\/WNL.44.6.1090"},{"key":"308_CR268","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1471-4159.1992.tb09439.x","volume":"59","author":"SJ Kish","year":"1992","unstructured":"Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, Chang L, et al. Brain cytochrome oxidase in Alzheimer\u2019s disease. J Neurochem. 1992;59:776\u20139.","journal-title":"J Neurochem"},{"key":"308_CR269","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062277","volume":"8","author":"A Bender","year":"2013","unstructured":"Bender A, Desplats P, Spencer B, Rockenstein E, Adame A, Elstner M, et al. TOM40 mediates mitochondrial dysfunction induced by \u03b1-synuclein accumulation in Parkinson\u2019s disease. PLoS ONE. 2013;8: e62277.","journal-title":"PLoS ONE"},{"key":"308_CR270","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bbadis.2018.11.013","volume":"1865","author":"Z Fu","year":"2019","unstructured":"Fu Z, Liu F, Liu C, Jin B, Jiang Y, Tang M, et al. Mutant huntingtin inhibits the mitochondrial unfolded protein response by impairing ABCB10 mRNA stability. Biochim Biophys Acta Bba Mol Basis Dis. 2019;1865:1428\u201335.","journal-title":"Biochim Biophys Acta Bba Mol Basis Dis"},{"key":"308_CR271","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2377-10-5","volume":"10","author":"P Hoyo","year":"2010","unstructured":"Hoyo P, del Garc\u00eda-Redondo A, Bustos F, de Molina JA, Sayed Y, Alonso-Navarro H, Caballero L, et al. Oxidative stress in skin fibroblasts cultures from patients with Parkinson\u2019s disease. BMC Neurol. 2010;10:5.","journal-title":"BMC Neurol"},{"key":"308_CR272","first-page":"750","volume":"9","author":"I Gonz\u00e1lez-Casacuberta","year":"2019","unstructured":"Gonz\u00e1lez-Casacuberta I, Ju\u00e1rez-Flores DL, Ezquerra M, Fucho R, Catal\u00e1n-Garc\u00eda M, Guitart-Mampel M, et al. Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations. Aging. 2019;9:3750\u201367.","journal-title":"Aging"},{"key":"308_CR273","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jmb.2018.08.019","volume":"430","author":"SM Bell","year":"2018","unstructured":"Bell SM, Barnes K, Clemmens H, Al-Rafiah AR, Al-ofi EA, Leech V, et al. Ursodeoxycholic Acid Improves Mitochondrial function and redistributes Drp1 in fibroblasts from patients with either sporadic or familial Alzheimer\u2019s disease. J Mol Biol. 2018;430:3942\u201353.","journal-title":"J Mol Biol"},{"key":"308_CR274","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fcell.2020.00423","volume":"8","author":"M Zilocchi","year":"2020","unstructured":"Zilocchi M, Colugnat I, Lualdi M, Meduri M, Marini F, Carregari VC, et al. Exploring the impact of PARK2 mutations on the total and mitochondrial proteome of human skin fibroblasts. Front Cell Dev Biol. 2020;8:23.","journal-title":"Front Cell Dev Biol"},{"key":"308_CR275","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.nmd.2007.12.008","volume":"18","author":"O Guillery","year":"2008","unstructured":"Guillery O, Malka F, Frachon P, Milea D, Rojo M, Lomb\u00e8s A. Modulation of mitochondrial morphology by bioenergetics defects in primary human fibroblasts. Neuromuscul Disord. 2008;18:319\u201330.","journal-title":"Neuromuscul Disord"},{"key":"308_CR276","doi-asserted-by":"publisher","first-page":"e2404","DOI":"10.1212\/WNL.0000000000009582","volume":"94","author":"J Yin","year":"2020","unstructured":"Yin J, Reiman EM, Beach TG, Serrano GE, Sabbagh MN, Nielsen M, et al. Effect of ApoE isoforms on mitochondria in Alzheimer disease. Neurology. 2020;94:e2404\u201311.","journal-title":"Neurology"},{"key":"308_CR277","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154582","volume":"11","author":"Y Chen","year":"2016","unstructured":"Chen Y, Liu C, Parker WD, Chen H, Beach TG, Liu X, et al. Mitochondrial DNA rearrangement spectrum in brain tissue of Alzheimer\u2019s disease: analysis of 13 cases. PLoS ONE. 2016;11: e0154582.","journal-title":"PLoS ONE"},{"key":"308_CR278","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(87)91553-8","volume":"436","author":"NR Sims","year":"1987","unstructured":"Sims NR, Finegan JM, Blass JP, Bowen DM, Neary D. Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res. 1987;436:31\u201338.","journal-title":"Brain Res"},{"key":"308_CR279","doi-asserted-by":"publisher","first-page":"099","DOI":"10.1523\/JNEUROSCI.2385-16.2017","volume":"37","author":"SH Baek","year":"2017","unstructured":"Baek SH, Park SJ, Jeong JI, Kim SH, Han J, Kyung JW, et al. Inhibition of Drp1 ameliorates synaptic depression, A\u03b2 deposition and cognitive impairment in an Alzheimer\u2019s disease model. J Neurosci. 2017;37:5099\u2013110.","journal-title":"J Neurosci"},{"key":"308_CR280","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neurobiolaging.2020.09.018","volume":"98","author":"E Gauba","year":"2021","unstructured":"Gauba E, Sui S, Tian J, Driskill C, Jia K, Yu C, et al. Modulation of OSCP mitigates mitochondrial and synaptic deficits in a mouse model of Alzheimer\u2019s pathology. Neurobiol Aging. 2021;98:73\u201377.","journal-title":"Neurobiol Aging"},{"key":"308_CR281","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1006\/nbdi.1996.0125","volume":"3","author":"SD Handran","year":"1997","unstructured":"Handran SD, Werth JL, DeVivo DC, Rothman SM. Mitochondrial morphology and intracellular calcium homeostasis in cytochrome oxidase-deficient human fibroblasts. Neurobiol Dis. 1997;3:287\u201398.","journal-title":"Neurobiol Dis"},{"key":"308_CR282","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11011-015-9667-z","volume":"30","author":"NE Gray","year":"2015","unstructured":"Gray NE, Quinn JF. Alterations in mitochondrial number and function in Alzheimer\u2019s disease fibroblasts. Metab Brain Dis. 2015;30:1275\u20138.","journal-title":"Metab Brain Dis"},{"key":"308_CR283","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1155\/2017\/9302761","volume":"2017","author":"P Mart\u00edn-Maestro","year":"2017","unstructured":"Mart\u00edn-Maestro P, Gargini R, Garc\u00eda E, Perry G, Avila J, Garc\u00eda-Escudero V. Slower dynamics and aged mitochondria in sporadic Alzheimer\u2019s disease. Oxid Med Cell Longev. 2017;2017:14.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"308_CR284","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.18632\/oncotarget.23640","volume":"9","author":"AU Joshi","year":"2017","unstructured":"Joshi AU, Saw NL, Shamloo M, Mochly-Rosen D. Drp1:Fis1 interaction mediates mitochondrial dysfunction bioenergetic failure and cognitive decline in Alzheimer\u2019s disease. Oncotarget. 2017;9(5):6128\u201343.","journal-title":"Oncotarget"},{"key":"308_CR285","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1242\/jcs.159186","volume":"129","author":"T MacVicar","year":"2016","unstructured":"MacVicar T, Langer T. OPA1 processing in cell death and disease\u2014the long and short of it. J Cell Sci. 2016;129:2297\u2013306.","journal-title":"J Cell Sci"},{"key":"308_CR286","doi-asserted-by":"publisher","first-page":"05","DOI":"10.1016\/j.tem.2015.12.001","volume":"27","author":"T Wai","year":"2016","unstructured":"Wai T, Langer T. Mitochondrial dynamics and metabolic regulation. Trends Endocrinol Metabolism. 2016;27:105\u201317.","journal-title":"Trends Endocrinol Metabolism"},{"key":"308_CR287","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fnmol.2017.00291","volume":"10","author":"P Mart\u00edn-Maestro","year":"2017","unstructured":"Mart\u00edn-Maestro P, Gargini R, Sproul AA, Garc\u00eda E, Ant\u00f3n LC, Noggle S, et al. Mitophagy failure in fibroblasts and iPSC-derived neurons of Alzheimer\u2019s disease-associated presenilin 1 mutation. Front Mol Neurosci. 2017;10:91.","journal-title":"Front Mol Neurosci"},{"key":"308_CR288","first-page":"371","volume":"53","author":"M Ramamoorthy","year":"2012","unstructured":"Ramamoorthy M, Sykora P, Scheibye-Knudsen M, Dunn C, Kasmer C, Zhang Y, et al. Sporadic Alzheimer disease fibroblasts display an oxidative stress phenotype. Free Radic Biolb Med. 2012;53:371\u201380.","journal-title":"Free Radic Biolb Med"},{"key":"308_CR289","doi-asserted-by":"publisher","first-page":"03","DOI":"10.3390\/brainsci11010103","volume":"11","author":"F Iannuzzi","year":"2021","unstructured":"Iannuzzi F, Frisardi V, Annunziato L, Matrone C. Might fibroblasts from patients with Alzheimer\u2019s disease reflect the brain pathology? a focus on the increased phosphorylation of amyloid precursor protein Tyr682 residue. Brain Sci. 2021;11:03.","journal-title":"Brain Sci"},{"key":"308_CR290","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/antiox10060938","volume":"10","author":"K Drabik","year":"2021","unstructured":"Drabik K, Mali\u0144ska D, Piecyk K, D\u0119bska-Vielhaber G, Vielhaber S, Duszy\u0144ski J, et al. Effect of chronic stress present in fibroblasts derived from patients with a sporadic form of AD on mitochondrial function and mitochondrial turnover. Antioxidants. 2021;10:38.","journal-title":"Antioxidants"},{"key":"308_CR291","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1073\/pnas.83.8.2758","volume":"83","author":"C Peterson","year":"1986","unstructured":"Peterson C, Goldman JE. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc Natl Acad Sci U S A. 1986;83:2758\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"308_CR292","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3233\/JAD-161088","volume":"57","author":"E T\u00f6nnies","year":"2017","unstructured":"T\u00f6nnies E, Trushina E. Oxidative stress synaptic dysfunction and Alzheimer\u2019s disease. J Alzheimers Dis. 2017;57:1105\u201321.","journal-title":"J Alzheimers Dis"},{"key":"308_CR293","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S0891-5849(02)01049-3","volume":"33","author":"C Cecchi","year":"2002","unstructured":"Cecchi C, Fiorillo C, Sorbi S, Latorraca S, Nacmias B, Bagnoli S, et al. Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer\u2019s patients. Free Radical Bio Med. 2002;33:1372\u20139.","journal-title":"Free Radical Bio Med"},{"key":"308_CR294","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nature03317","volume":"434","author":"T Nakagawa","year":"2005","unstructured":"Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature. 2005;434:652\u20138.","journal-title":"Nature"},{"key":"308_CR295","first-page":"98","volume":"1802","author":"H Du","year":"2010","unstructured":"Du H, Yan SS. Mitochondrial permeability transition pore in Alzheimer\u2019s disease: cyclophilin D and amyloid beta. Biochim Biophys Acta. 2010;1802:198\u2013204.","journal-title":"Biochim Biophys Acta"},{"key":"308_CR296","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1074\/jbc.M407500200","volume":"279","author":"G Petrosillo","year":"2004","unstructured":"Petrosillo G, Ruggiero FM, Pistolese M, Paradies G. Ca2+-induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms -role of cardiolipin. J Biol Chem. 2004;279:53103\u20138.","journal-title":"J Biol Chem"},{"key":"308_CR297","first-page":"444","volume":"18","author":"RX Santos","year":"2013","unstructured":"Santos RX, Correia SC, Zhu X, Smith MA, Moreira PI, Castellani RJ, et al. Mitochondrial DNA oxidative damage and repair in aging and Alzheimer\u2019s disease. Antioxid Redox Sign. 2013;18:2444\u201357.","journal-title":"Antioxid Redox Sign"},{"key":"308_CR298","first-page":"323","volume":"80","author":"SM Monte","year":"2000","unstructured":"Monte SM, de la Luong T, Neely TR, Robinson D, Wands JR. Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer\u2019s disease. Lab Invest. 2000;80:1323\u201335.","journal-title":"Lab Invest"},{"key":"308_CR299","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1471-4159.2005.03053.x","volume":"93","author":"J Wang","year":"2005","unstructured":"Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer\u2019s disease. J Neurochem. 2005;93:953\u201362.","journal-title":"J Neurochem"},{"key":"308_CR300","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000085555","volume":"53","author":"M Grazina","year":"2005","unstructured":"Grazina M, Silva F, Santana I, Pratas J, Santiago B, Oliveira M, et al. Mitochondrial DNA variants in a Portuguese population of patients with Alzheimer\u2019s disease. Eur Neurol. 2005;53:121\u20134.","journal-title":"Eur Neurol"},{"key":"308_CR301","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0304-3940(97)00741-6","volume":"236","author":"D Curti","year":"1997","unstructured":"Curti D, Rognoni F, Gasparini L, Cattaneo A, Paolillo M, Racchi M, et al. Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer\u2019s disease (AD) patients. Neurosci Lett. 1997;236:13\u20136.","journal-title":"Neurosci Lett"},{"key":"308_CR302","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/jpm10020032","volume":"10","author":"SM Bell","year":"2020","unstructured":"Bell SM, Marco MD, Barnes K, Shaw PJ, Ferraiuolo L, Blackburn DJ, et al. Deficits in mitochondrial spare respiratory capacity contribute to the neuropsychological changes of Alzheimer\u2019s disease. J Person Med. 2020;10:2.","journal-title":"J Person Med"},{"issue":"6","key":"308_CR303","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3390\/antiox10060938","volume":"10","author":"K Drabik","year":"2021","unstructured":"Drabik K, Mali\u0144ska D, Piecyk K, D\u0119bska-Vielhaber G, Vielhaber S, Duszy\u0144ski J, et al. Effect of chronic stress present in fibroblasts derived from patients with a sporadic form of AD on mitochondrial function and mitochondrial turnover. Antioxidants (Basel). 2021;10(6):938.","journal-title":"Antioxidants (Basel)"},{"key":"308_CR304","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/ijms21030770","volume":"21","author":"L Galla","year":"2020","unstructured":"Galla L, Redolfi N, Pozzan T, Pizzo P, Greotti E. Intracellular calcium dysregulation by the Alzheimer\u2019s disease-linked protein Presenilin 2. Int J Mol Sci. 2020;21:70.","journal-title":"Int J Mol Sci"},{"key":"308_CR305","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1038\/s41598-017-14420-x","volume":"7","author":"KC Sonntag","year":"2017","unstructured":"Sonntag KC, Ryu WI, Amirault KM, Healy RA, Siegel AJ, McPhie DL, et al. Late-onset Alzheimer\u2019s disease is associated with inherent changes in bioenergetics profiles. Sci Rep. 2017;7:4038.","journal-title":"Sci Rep"},{"key":"308_CR306","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose A, Beal MF. Mitochondrial dysfunction in Parkinson\u2019s disease. J Neurochem. 2016;139:216\u201331.","journal-title":"J Neurochem"},{"key":"308_CR307","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fnins.2017.00737","volume":"11","author":"JMY Teves","year":"2018","unstructured":"Teves JMY, Bhargava V, Kirwan KR, Corenblum MJ, Justiniano R, Wondrak GT, et al. Parkinson\u2019s disease skin fibroblasts display signature alterations in growth redox homeostasis mitochondrial function and autophagy. Front Neurosci. 2018;11:37.","journal-title":"Front Neurosci"},{"key":"308_CR308","doi-asserted-by":"publisher","first-page":"e16746","DOI":"10.1371\/journal.pone.0016746","volume":"6","author":"A Rakovic","year":"2011","unstructured":"Rakovic A, Gr\u00fcnewald A, Kottwitz J, Br\u00fcggemann N, Pramstaller PP, Lohmann K, et al. Mutations in PINK1 and Parkin impair ubiquitination of mitofusins in human fibroblasts. PLoS ONE. 2011;6:e16746.","journal-title":"PLoS ONE"},{"key":"308_CR309","doi-asserted-by":"publisher","first-page":"013","DOI":"10.1038\/s41556-018-0176-2","volume":"20","author":"K Palikaras","year":"2018","unstructured":"Palikaras K, Lionaki E, Tavernarakis N. Mechanisms of mitophagy in cellular homeostasis physiology and pathology. Nat Cell Biol. 2018;20:1013\u201322.","journal-title":"Nat Cell Biol"},{"key":"308_CR310","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1073\/pnas.1221132110","volume":"110","author":"ES Vincow","year":"2013","unstructured":"Vincow ES, Merrihew G, Thomas RE, Shulman NJ, Beyer RP, MacCoss MJ, et al. The PINK1\u2013Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proc Natl Acad Sci U S A. 2013;110:6400\u201305.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"308_CR311","doi-asserted-by":"publisher","first-page":"00","DOI":"10.3389\/fneur.2013.00100","volume":"4","author":"K Grenier","year":"2013","unstructured":"Grenier K, McLelland GL, Fon EA. Parkin- and PINK1-dependent mitophagy in neurons: will the real pathway please stand up? Front Neurol. 2013;4:00.","journal-title":"Front Neurol"},{"key":"308_CR312","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1073\/pnas.0911187107","volume":"107","author":"C Vives-Bauza","year":"2010","unstructured":"Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RLA, Kim J, et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci USA. 2010;107:378\u2013383.","journal-title":"Proc Natl Acad Sci USA"},{"key":"308_CR313","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ana.21492","volume":"64","author":"H Mortiboys","year":"2008","unstructured":"Mortiboys H, Thomas KJ, Koopman WJH, Klaffke S, Abou-Sleiman P, Olpin S, et al. Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol. 2008;64:555\u201365.","journal-title":"Ann Neurol"},{"key":"308_CR314","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1523\/JNEUROSCI.0979-08.2008","volume":"28","author":"O Anichtchik","year":"2008","unstructured":"Anichtchik O, Diekmann H, Fleming A, Roach A, Goldsmith P, Rubinsztein DC. Loss of PINK1 function affects development and results in neurodegeneration in zebrafish. J Neurosci. 2008;28:8199\u2013207.","journal-title":"J Neurosci"},{"key":"308_CR315","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1523\/JNEUROSCI.0719-07.2007","volume":"27","author":"N Exner","year":"2007","unstructured":"Exner N, Treske B, Paquet D, Holmstr\u00f6m K, Schiesling C, Gispert S, et al. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by Parkin. J Neurosci. 2007;27:12413\u20138.","journal-title":"J Neurosci"},{"key":"308_CR316","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/hmg\/ddq419","volume":"19","author":"ME Gegg","year":"2010","unstructured":"Gegg ME, Cooper JM, Chau KY, Rojo M, Schapira AHV, Taanman JW. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1\/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet. 2010;19:4861\u201370.","journal-title":"Hum Mol Genet"},{"key":"308_CR317","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/hmg\/ddq215","volume":"19","author":"A Rakovic","year":"2010","unstructured":"Rakovic A, Gr\u00fcnewald A, Seibler P, Ramirez A, Kock N, Orolicki S, et al. Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients. Hum Mol Genet. 2010;19:3124\u201337.","journal-title":"Hum Mol Genet"},{"key":"308_CR318","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s12035-018-1206-6","volume":"56","author":"SMS Yakhine-Diop","year":"2019","unstructured":"Yakhine-Diop SMS, Niso-Santano M, Rodr\u00edguez-Arribas M, G\u00f3mez-S\u00e1nchez R, Mart\u00ednez-Chac\u00f3n G, Uribe-Carretero E, et al. Impaired mitophagy and protein acetylation levels in fibroblasts from Parkinson\u2019s disease patients. Mol Neurobiol. 2019;56:2466\u201381.","journal-title":"Mol Neurobiol"},{"key":"308_CR319","first-page":"23","volume":"8","author":"C Mytilineou","year":"1994","unstructured":"Mytilineou C, Werner P, Molinari S, Rocco A, Cohen G, Yahr MD. Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson\u2019s disease. J Neural Transm. 1994;8:223\u20138.","journal-title":"J Neural Transm"},{"key":"308_CR320","first-page":"19","volume":"26","author":"WD Parker","year":"2013","unstructured":"Parker WD, Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic parkinson\u2019s disease. Ann Neurol. 2013;26:719\u201323.","journal-title":"Ann Neurol"},{"key":"308_CR321","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.neurobiolaging.2004.02.020","volume":"25","author":"R Smigrodzki","year":"2004","unstructured":"Smigrodzki R, Parks J, Parker WD. High frequency of mitochondrial complex I mutations in Parkinson\u2019s disease and aging. Neurobiol Aging. 2004;25:1273\u201381.","journal-title":"Neurobiol Aging"},{"key":"308_CR322","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ng1778","volume":"38","author":"Y Kraytsberg","year":"2006","unstructured":"Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet. 2006;38:518\u201320.","journal-title":"Nat Genet"},{"key":"308_CR323","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.bcp.2004.02.015","volume":"67","author":"D Ben-Shachar","year":"2004","unstructured":"Ben-Shachar D, Zuk R, Gazawi H, Ljubuncic P. Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders. Biochem Pharmacol. 2004;67:1965\u201374.","journal-title":"Biochem Pharmacol"},{"key":"308_CR324","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.brainres.2007.10.061","volume":"1189","author":"WD Parker","year":"2008","unstructured":"Parker WD, Parks JK, Swerdlow RH. Complex I deficiency in Parkinson\u2019s disease frontal cortex. Brain Res. 2008;1189:215\u20138.","journal-title":"Brain Res"},{"key":"308_CR325","doi-asserted-by":"publisher","first-page":"C881","DOI":"10.1152\/ajpcell.00104.2005","volume":"289","author":"WJH Koopman","year":"2005","unstructured":"Koopman WJH, Visch HJ, Verkaart S, Van Heuvel LWPJ, den Smeitink JAM, Willems PHGM. Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency. Am J Physiol. 2005;289:C881\u201390.","journal-title":"Am J Physiol"},{"key":"308_CR326","doi-asserted-by":"publisher","first-page":"05","DOI":"10.1016\/j.neulet.2007.01.026","volume":"415","author":"I Ferrer","year":"2007","unstructured":"Ferrer I, Perez E, Dalf\u00f3 E, Barrachina M. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson\u2019s disease. Neurosci Lett. 2007;415:205\u20139.","journal-title":"Neurosci Lett"},{"key":"308_CR327","doi-asserted-by":"publisher","first-page":"089","DOI":"10.1074\/jbc.M710012200","volume":"283","author":"L Devi","year":"2008","unstructured":"Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK. Mitochondrial import and accumulation of \u03b1-synuclein impair complex i in human dopaminergic neuronal cultures and parkinson disease brain. J Biol Chem. 2008;283:9089\u2013100.","journal-title":"J Biol Chem"},{"key":"308_CR328","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neulet.2010.09.061","volume":"486","author":"SJ Chinta","year":"2010","unstructured":"Chinta SJ, Mallajosyula JK, Rane A, Andersen JK. Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett. 2010;486:235\u20139.","journal-title":"Neurosci Lett"},{"key":"308_CR329","first-page":"75","volume":"1","author":"SK Mak","year":"2011","unstructured":"Mak SK, Tewari D, Tetrud JW, Langston JW, Sch\u00fcle B. Mitochondrial dysfunction in skin fibroblasts from a Parkinson\u2019s disease patient with an alpha-synuclein triplication. J Park Dis. 2011;1:175\u201383.","journal-title":"J Park Dis"},{"key":"308_CR330","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fgene.2015.00078","volume":"6","author":"MC Zanellati","year":"2015","unstructured":"Zanellati MC, Monti V, Barzaghi C, Reale C, Nardocci N, Albanese A, et al. Mitochondrial dysfunction in Parkinson disease: evidence in mutant PARK2 fibroblasts. Front Genetics. 2015;6:8.","journal-title":"Front Genetics"},{"key":"308_CR331","doi-asserted-by":"publisher","first-page":"e12962","DOI":"10.1371\/journal.pone.0012962","volume":"5","author":"A Gr\u00fcnewald","year":"2010","unstructured":"Gr\u00fcnewald A, Voges L, Rakovic A, Kasten M, Vandebona H, Hemmelmann C, et al. Mutant Parkin impairs mitochondrial function and morphology in human fibroblasts. PLoS ONE. 2010;5:e12962.","journal-title":"PLoS ONE"},{"key":"308_CR332","doi-asserted-by":"publisher","first-page":"005","DOI":"10.1007\/s11011-018-0308-1","volume":"33","author":"P J\u0119drak","year":"2018","unstructured":"J\u0119drak P, Mozolewski P, W\u0119grzyn G, Wi\u0119ckowski MR. Mitochondrial alterations accompanied by oxidative stress conditions in skin fibroblasts of Huntington\u2019s disease patients. Metab Brain Dis. 2018;33:2005\u201317.","journal-title":"Metab Brain Dis"},{"key":"308_CR333","first-page":"7","volume":"117","author":"F Squitieri","year":"2009","unstructured":"Squitieri F, Falleni A, Cannella M, Orobello S, Fulceri F, Lenzi P, et al. Abnormal morphology of peripheral cell tissues from patients with Huntington disease. J Neural Transm. 2009;117:7.","journal-title":"J Neural Transm"},{"key":"308_CR334","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nm.2313","volume":"17","author":"W Song","year":"2011","unstructured":"Song W, Chen J, Petrilli A, Liot G, Klinglmayr E, Zhou Y, et al. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med. 2011;17:377\u201382.","journal-title":"Nat Med"},{"key":"308_CR335","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/ana.410430321","volume":"43","author":"J Arenas","year":"1998","unstructured":"Arenas J, Campos Y, Ribacoba R, Mart\u00edn MA, Rubio JC, Ablanedo P, et al. Complex I defect in muscle from patients with Huntington\u2019s disease: complex I defect in HD. Ann Neurol. 1998;43:397\u2013400.","journal-title":"Ann Neurol"},{"key":"308_CR336","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11011-017-0026-0","volume":"32","author":"P J\u0119drak","year":"2017","unstructured":"J\u0119drak P, Krygier M, To\u0144ska K, Drozd M, Kaliszewska M, Bartnik E, et al. Mitochondrial DNA levels in Huntington disease leukocytes and dermal fibroblasts. Metab Brain Dis. 2017;32:1237\u201347.","journal-title":"Metab Brain Dis"},{"key":"308_CR337","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1091\/mbc.E18-09-0590","volume":"29","author":"CLK Hung","year":"2018","unstructured":"Hung CLK, Maiuri T, Bowie LE, Gotesman R, Son S, Falcone M, et al. A patient-derived cellular model for Huntington\u2019s disease reveals phenotypes at clinically relevant CAG lengths. Mol Biol Cell. 2018;29:2809\u201320.","journal-title":"Mol Biol Cell"},{"key":"308_CR338","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-016-0316-5","volume":"4","author":"E Onesto","year":"2016","unstructured":"Onesto E, Colombrita C, Gumina V, Borghi MO, Dusi S, Doretti A, et al. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathologica Commun. 2016;4:7.","journal-title":"Acta Neuropathologica Commun"},{"key":"308_CR339","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.nbd.2018.07.027","volume":"119","author":"EC Genin","year":"2018","unstructured":"Genin EC, Bannwarth S, Lespinasse F, Ortega-Vila B, Fragaki K, Itoh K, et al. Loss of MICOS complex integrity and mitochondrial damage but not TDP-43 mitochondrial localisation are likely associated with severity of CHCHD10-related diseases. Neurobiol Dis. 2018;119:159\u201371.","journal-title":"Neurobiol Dis"},{"key":"308_CR340","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jns.2005.02.004","volume":"232","author":"M Rizzardini","year":"2005","unstructured":"Rizzardini M, Mangolini A, Lupi M, Ubezio P, Bendotti C, Cantoni L. Low levels of ALS-linked Cu\/Zn superoxide dismutase increase the production of reactive oxygen species and cause mitochondrial damage and death in motor neuron-like cells. J Neurol Sci. 2005;232:95\u2013103.","journal-title":"J Neurol Sci"},{"key":"308_CR341","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.neurobiolaging.2015.07.013","volume":"36","author":"SP Allen","year":"2015","unstructured":"Allen SP, Duffy LM, Shaw PJ, Grierson AJ. Altered age-related changes in bioenergetic properties and mitochondrial morphology in fibroblasts from sporadic amyotrophic lateral sclerosis patients. Neurobiol Aging. 2015;36:2893\u2013903.","journal-title":"Neurobiol Aging"},{"key":"308_CR342","doi-asserted-by":"publisher","first-page":"13620","DOI":"10.1016\/j.expneurol.2021.113620","volume":"339","author":"G Debska-Vielhaber","year":"2021","unstructured":"Debska-Vielhaber G, Miller I, Peeva V, Zuschratter W, Walczak J, Schreiber S, et al. Impairment of mitochondrial oxidative phosphorylation in skin fibroblasts of SALS and FALS patients is rescued by in vitro treatment with ROS scavengers. Exp Neurol. 2021;339:13620.","journal-title":"Exp Neurol"},{"key":"308_CR343","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/s41598-018-22318-5","volume":"8","author":"M Szelechowski","year":"2018","unstructured":"Szelechowski M, Amoedo N, Obre E, L\u00e9ger C, Allard L, Bonneu M, et al. Metabolic reprogramming in amyotrophic lateral sclerosis. Sci Rep. 2018;8:953.","journal-title":"Sci Rep"},{"key":"308_CR344","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-510X(96)00070-6","volume":"139","author":"GA Jansen","year":"1996","unstructured":"Jansen GA, Wanders RJA, J\u00f6bsis GJ, Bolhuis PA, de Jong JM. Evidence against increased oxidative stress in fibroblasts from patients with non-superoxide-dismutase-1 mutant familial amyotrophic lateral sclerosis. J Neurol Sci. 1996;139:91\u20134.","journal-title":"J Neurol Sci"},{"key":"308_CR345","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/ana.410430407","volume":"43","author":"T Aguirre","year":"1998","unstructured":"Aguirre T, Bosch L, Van D, Goetschalckx K, Tilkin P, Mathijis G, et al. Increased sensitivity of fibroblasts from amyotrophic lateral sclerosis patients to oxidative stress. Ann Neurol. 1998;43:452\u20137.","journal-title":"Ann Neurol"},{"key":"308_CR346","first-page":"1","volume":"9","author":"MT Carr\u00ec","year":"2015","unstructured":"Carr\u00ec MT, Valle C, Bozzo F, Cozzolino M. Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS. Front Cell Neurosci. 2015;9:1.","journal-title":"Front Cell Neurosci"},{"key":"308_CR347","doi-asserted-by":"publisher","first-page":"e75523","DOI":"10.1371\/journal.pone.0075523","volume":"8","author":"A Siebel","year":"2013","unstructured":"Siebel A, Cubillos-Rojas M, Santos RC, Schneider T, Bonan CD, Bartrons R, et al. Contribution of S6K1\/MAPK signaling pathways in the response to oxidative stress: activation of RSK and MSK by hydrogen peroxide. PLoS ONE. 2013;8:e75523.","journal-title":"PLoS ONE"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-022-00308-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-022-00308-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-022-00308-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T11:18:29Z","timestamp":1727522309000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-022-00308-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":347,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["308"],"URL":"https:\/\/doi.org\/10.1186\/s40035-022-00308-y","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,4]]},"assertion":[{"value":"2 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}